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RESUMO 
 
O objetivo deste estudo foi avaliar o efeito da mistura comercial do líquido da 
casca de castanha de caju e do óleo de mamona (Essential, Oligo Basics 
Agroind. Ltda., Cascavel, Brasil) no desempenho, na microbiota e no sistema 
imune de frangos de corte desafiados ou não por coccidiose. Ao total 864 
pintos machos (Cobb) de um dia de idade foram distribuídos aleatoriamente em 
6 tratamentos (8 boxes/tratamento e 18 pintos/box) em um desenho fatorial 3 x 
2 com 3 aditivos: controle (sem aditivo), 100 ppm de monensina ou 0,15% de 
Essential e 2 níveis de desafio aos 14 dias de idade: não desafiados ou 
inoculados por gavagem com 1mL de solução contendo oocistos esporulados 
de E. tenella, E. acervulina e E. máxima. Os resultados foram divididos em dois 
artigos. Artigo 1: Na primeira semana após desafio, as aves desafiadas 
suplementadas com monensina apresentaram maior ganho de peso (GP), 
consumo de ração (CR) e melhor conversão alimentar (CA) (P <0,05), porém 
na segunda semana o Essential apresentou maior GP e melhor CA (P <0,05), 
aos 42 dias de idade, ambos os grupos não se diferiram em GP, CR, PV e 
foram maiores do que o controle (P <0,05). A utilização de monensina em aves 
desafiadas reduziu o número cópias do domínio bactéria e de E.coli (P<0,05), 
por sua vez, a suplementação com Essential reduziu Clostridium Cluster XIV, 
Clostridium perfringens e Staphylococcus aureus em relação aos demais 
tratamentos (P<0,05). As aves não desafiadas que receberam Essential ou 
monensina apresentaram menor população de C.perfringens e S. aureus 
(P<0,05). Artigo 2: O grupo que recebeu Essential aumentou a expressão 
gênica de IFN-y, IL-6 e TNF-α (P<0,05) e o grupo controle aumentou a 
expressão gênica de COX-2 e IL-1 em relação aos demais tratamentos 
(P<0,05). As aves não desafiadas que receberam monensina apresentaram 
maior expressão gênica de IFN-y, COX-2 e IL-1 comparadas aos demais 
tratamentos (P<0,05), ao contrário do grupo com Essential que reduziu a 
expressão gênica com exceção do TNF-α. Aos 7 e 14 dias após o desafio 
houve maior excreção de oocistos para o grupo controle, Essential e 
monensina não diferiram-se (P>0,05). Assim, o Essential melhorou o 
desempenho de frangos de corte infectados por coccidiose após a segunda 
semana do desafio e atuou como um modulador da microbiota intestinal e do 
sistema imune, direcionando a resposta inflamatória contra o parasita.  
  
Palavras-chave: Citocinas. Eimeria. Imunidade. Microbiota. Saúde intestinal. 
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ABSTRACT 
 
The objective of this study was to evaluate the effects of a commercial mixture 
of cashew shell liquid and castor oil (Essential, Oligo Basics Agroind. Ltda., 
Cascavel, Brazil) on growth performance, immunity and microbiota in broilers 
challenged with coccidiosis. A total of 864 one-day-old male chicks (Cobb) were 
randomly assigned to 6 treatments (8 pens/treatment and 18 birds/pen) in a 3 x 
2 factorial design with 3 additives: control (no additive), 100 ppm of monensin, 
and 0.15% of Essential; and 2 challenge levels at 14 days of age: no challenge 
and inoculation by gavage of 1 ml of a solution containing sporulated oocysts of 
E. tenella, E. acervulina, and E. maxima. The results were divided into two 
articles. Article 1: In the first week after challenge, challenged birds 
supplemented with monensin showed higher LW, WG, FI  and better FCR (P 
<0.05), but in the second week Essential presented higher WG  and better FCR 
(P <0.05), at 42 days of age, both groups did not differ in WG, FI,  and LW and 
were higher than the control (P <0.05). The use of monensin in challenged birds 
reduced the number of copies of the bacteria domain and of E.coli (P<0,05). In 
turn, Essential supplementation reduced Clostridium Cluster XIV, Clostridium 
perfringens and Staphylococcus aureus in relation to the other treatments 
(P<0,05). The unchallenged birds that received Essential or monensin 
presented a lower population of C.perfringens and S. aureus (P<0,05). In 
addition, Essential presented higher number of copies of Lactobacillus spp., 
followed by monensin and control (P <0.05). Article 2: The group that received 
Essential increased the gene expression of IFN-y, IL-6 e TNF-α (P<0,05) and 
the control group increased the gene expression of COX-2 and IL-1 in relation 
to the other treatments (P <0.05). The unchallenged birds that received 
monensin presented upregulated expression of IFN-y, COX-2 and IL-1 
compared to the other treatments (P <0.05), unlike the Essential group, which 
reduced gene expression with the exception of TNF-α. At 7 and 14 days after 
the challenge there was a higher excretion of oocysts for the control group, 
Essential and monensin did not differ (P>0,05). Thus, Essential improved the 
performance of coccidiosis-infected broiler chickens after the second week of 
challenge, as well as acts as a modulator of intestinal flora and immune system, 
directing the inflammatory response against the parasite. 
 
 
Keywords: Cytokines. Eimeria. Immunity. Gut health. Microbiota. 
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1. INTRODUÇÃO 
 
A interação entre a nutrição, a imunidade e a microbiota intestinal 
está diretamente envolvida no crescimento e na produtividade animal. Tanto a 
nutrição quanto a microbiota pode modular a suscetibilidade da ave contra 
desafios infecciosos; a suscetibilidade pode estar relacionada com a resistência 
ou resiliência. A resistência é a capacidade de exclusão do patógeno; por outro 
lado, a resiliência é a capacidade do frango de manter sua produtividade 
durante o desafio infeccioso. O intuito da nutrição e aumentar a resiliência das 
aves (Machado e Fontes, 2005). 
 A coccidiose aviária é uma doença intestinal causada por 
protozoários do gênero Eimeria spp. que se multiplicam no intestino causando 
destruição tecidual e prejudicando a digestão e a absorção de nutrientes, 
resultando em diarreia aquosa ou hemorrágica (Berchieri Jr. et al., 2009). A 
infecção por Eimeria spp. também permite a proliferação de microrganismos 
patogênicos como as bactérias do gênero Clostridium spp. Estudos têm 
demonstrado que a coccidiose altera drasticamente a microbiota intestinal 
(Hume et al., 2006; Oviedo-Rondón et al., 2006). Em conjunto com o 
desequilíbrio da microbiota intestinal, a coccidiose desencadeia no hospedeiro 
uma resposta imune complexa, porque o parasita exibe um ciclo de vida 
extracelular e intracelular. No entanto, a alta mortalidade não é comum. Na 
maioria dos casos ocorre a infecção subclínica, o que dificulta o diagnóstico da 
doença em tempo hábil para começar um tratamento antes que ocorra a perda 
de desempenho. Durante a infecção subclínica ocorre uma diminuição da 
digestão e absorção de nutrientes em virtude das lesões no trato 
gastrointestinal e consequentemente queda no desempenho (Cornelissen et 
al., 2009).   
Alguns fitogênicos podem atuar como agentes antimicrobianos e 
anti-inflamatórios com efeitos similares aos fármacos utilizados na produção 
animal, pois são compostos formados por uma mistura complexa de 
substâncias voláteis como os hidrocarbonetos terpênicos, os álcoois simples, 
os aldeídos, entre outros que são farmacologicamentes ativos (Applegate et al., 
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2010). A vantagem é que essa mistura de compostos ativos pode diminuir o 
desenvolvimento de resistência microbiana e reduzir o potencial de resíduos 
tóxicos nos produtos de origem animal. 
Dentro da categoria dos fitogênicos os óleos funcionais são definidos 
como aqueles que têm uma ação além do valor nutricional (Murakami et al., 
2014). Um desses produtos trata de uma mistura do líquido da casca de 
castanha de caju e do óleo de mamona cujo produto comercial é chamado de 
Essential® (Essential, US Patent N°. 8,377,485 B2: Oligo Basics Agroind. Ltda., 
Rua Sérgio Gasparetto 503, Cascavel, PR-CEP, Brazil). O Essential tem como 
compostos ativos o cardanol (200g/kg), o acido ricinoleico (90g/kg) e o cardol 
(40g/kg). Avaliando essa mistura na dieta de frangos de corte desafiados por 
coccidiose, Murakami et al (2014) observaram um aumento no ganho de peso 
e uma melhoria na conversão alimentar, além de um ganho  de 100 kcal de 
energia metabolizável na dieta quando comparada com  a controle (Bess et al., 
2012; Murakami et al., 2014). Segundo Bess et al (2012), esse aumento na 
disponibilidade de energia pode estar relacionado com os efeitos 
antimicrobianos e anti-inflamatórios dos óleos funcionais . No entanto, não há 
na literatura trabalhos que comprovem a ação antimicrobiana deste produto in 
vivo. 
Entender os mecanismos fisiológicos e metabólicos pelos quais os 
aditivos utilizados na dieta afetam o desempenho, a imunidade e o ecossistema 
da microbiota permite a formulação de dietas práticas de produção que 
otimizem a resistência a doenças e melhorem o desempenho animal. Assim, o 
presente trabalho foi desenhado com o objetivo de avaliar os efeitos da 
suplementação da mistura comercial do líquido da casca de castanha de caju e 
do óleo de mamona na dieta de frangos de corte desafiados por coccidiose. 
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2. REVISÃO BIBLIOGRÁFICA 
2.2 Sistema imunológico  
O sistema imune é dividido didaticamente em três linhas de defesa. A 
primeira linha de defesa é constituída pelas barreiras físicas que evitam a 
penetração do agente; a segunda é a imunidade inata, composta por células e 
moléculas responsáveis pela resposta imediata, conferindo uma proteção inicial; 
e a terceira é a imunidade adquirida (Tizard, 2009). A imunidade inata é linha de 
defesa do hospedeiro capaz de induzir uma resposta rápida e menos específica. 
O reconhecimento dos patógenos na imunidade inata é mediado pelos 
Receptores de Reconhecimento de Padrões (RRPs), que reconhecem padrões 
moleculares associados aos patógenos, os denominados de PAMPs e padrões 
moleculares associados aos danos, conhecidos como DAMPs. Os PAMPs são 
as estruturas microbianas comuns e quimicamente diferentes dos componentes 
normais do organismo. Uma das principais famílias dos PAMPs é a dos 
receptores Toll-like (TLRs). Os DAMPs são ligantes endógenos liberados 
durante o dano tecidual ocorrido em sítios infecciosos e de necrose celular 
(Abbas et al., 2011).  
A ativação dos TLR, conduz à ativação do fator neural kappa B (NF-
kB) via de transdução do sinal de indução de uma grande variedade de genes 
do hospedeiro envolvidos na imunidade inata, tais como citocinas, quimiocinas e 
de síntese de óxido nítrico. Além disso, fazem parte da imunidade inata as 
células dendríticas, células natural killer e as células fagocíticas como os 
macrófagos e os neutrófilos Nas aves os neutrófilos são denominados 
heterofilos. A defesa do organismo é centralizada no local da infecção, 
estabelecendo uma resposta inflamatória através das citocinas pró-inflamatórias 
(TNFα, IL-1, IL-6, IL-12), que juntas às células defensoras, evitam que os 
patógenos se desloquem para áreas não infectadas. Se o sistema imune inato 
não for capaz de prevenir o acesso ou destruir o microrganismo invasor, a 
imunidade adquirida é desencadeada (Scroferneker, 1996; Tizard, 2009; Abbas, 
et al., 2012). 
O sistema imune adquirido está dividido em dois tipos de resposta e 
é dependente do microrganismo invasor. A primeira é a humoral, que é mediada 
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por linfócitos B e é desencadeada por microrganismos que permanecem nos 
fluidos corporais, ou seja, extracelularmente. A segunda é a resposta imune 
celular, mediada por linfócitos T e ocorre quando o patógeno encontra-se 
intracelularmente (Tizard, 2009; Abbas et al., 2012). 
A imunidade humoral é mediada por anticorpos produzidos pelos 
linfócitos B com função de neutralizar o desenvolvimento do agente infeccioso e 
sinalizar para eliminação dos mesmos. A resposta imune celular é composta 
pelos linfócitos T que têm uma especificidade restrita, reconhecem somente 
antígenos peptídicos ligados a moléculas do hospedeiro que são as proteínas 
do complexo de histocompatibilidade (MHC). A resposta imune celular conta 
com a ativação de linfócitos T citotóxicos, células natural killers (NK) e 
macrófagos. Os linfócitos T citotóxicos agem liberando produtos citolíticos na 
área de contato com a célula infectada induzindo-a a apoptose.  A resposta 
mediada pelas células T é extremamente efetiva no mecanismo de defesa 
contra agentes intracelulares, como vírus, protozoários, fungos e bactérias 
intracelulares. As células T podem exercer sua função através da citotoxicidade 
mediada por células CD8+ ou através da secreção de citocinas que vão ativar 
macrófagos para destruir os agentes intracelulares (Abbas et al., 2015). 
 
 
2.1.1 Custo do sistema imune 
A interação entre a nutrição e a imunidade é particularmente 
importante para o crescimento e produtividade animal. A composição da dieta 
pode modular a suscetibilidade da ave contra desafios infecciosos. A 
suscetibilidade pode estar relacionada com a resistência ou resiliência, sendo a 
resistência a capacidade de exclusão do patógeno e a resiliência a capacidade 
do animal em manter a produtividade durante o desafio infeccioso. O intuito da 
nutrição e aumentar a resiliência dos animais (Machado e Fontes, 2005; Yang 
et al., 2003). 
Durante o desafio imunológico o custo energético é maior que o 
proteico ou de outros substratos, devido a alta taxa de turnover celular com 
eficiente reutilização de nutrientes. Quando há um sistema imune ativo há uma 
hipertrofia do fígado para a produção de proteínas da fase aguda de resposta. 
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Também o sistema imune aumenta sua exigência de minerais traço que atuam 
como cofatores para as proteínas da fase aguda de resposta (Klasing, 2007).A 
fase aguda de resposta é caracterizada pela diminuição do apetite, aumento da 
taxa metabólica basal, aumento da degradação do músculo esquelético e 
aumento da síntese hepática de proteínas da fase aguda. Essas mudanças 
ocorrem mediadas pelas citocinas pró-inflamatórias (IL-1, IL-6 e TNF-α), que 
por sua vez desencadeiam a liberação de hormônios que reduzem a taxa de 
crescimento. Como exemplo, o estímulo do hormônio adenocorticotrófico 
(ACTH) pelos linfócitos T e macrófagos vai aumentar a síntese de 
glicocorticóide que vai atuar na musculatura esquelética causando liberação de 
aminoácidos para glicogeneogênese ou síntese de proteínas da fase aguda de 
resposta (Klasing; Korver, 1997). Além disso, quando receptores específicos 
para TNF-α do cérebro de aves são ativados há uma redução significativa de 
hormônios como o GHRH (hormônio de liberação do hormônio de crescimento) 
e TRH (hormônio de liberação de tireotropina), reduzindo assim a taxa 
metabólica e o crescimento (Elsasser et al., 1997).  
Essas respostas do sistema imune têm efeito sistêmico alterando o 
partilhamento de nutrientes (Klasing et al., 1997). Há uma relação antagônica 
entre os processos fisiológicos da imunidade e do crescimento. Durante a 
resposta inflamatória cerca de 70% da queda de desempenho é devido à 
diminuição do consumo de alimentos, porém o restante fica por conta da 
redução do metabolismo e da menor absorção de nutrientes (Klasing et al., 
1987). Jiang et al. (2010), observaram queda de 22,5% na taxa de ganho de 
peso de frangos de corte desafiados com lipopolissacarídeos bacterianos (LPS) 
comparado ao grupo não desafiado, alimentado ad libitum. O grupo de aves 
que não foi desafiado, mas que teve o fornecimento de ração pareado com os 
desafiados com LPS também reduziu o crescimento, porém não tão 
intensamente. Conclui-se que apenas 59% da queda de desempenho foi em 
função da redução no consumo de ração, enquanto 41% foi devido a outros 
fatores, provavelmente associados a resposta imune. Comparando a exigência 
de lisina do sistema imune em mantença e ativado, o requerimento de lisina 
passou de 1-2% para 6-7%, respectivamente. Isso porque houve um aumento 
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na produção de anticorpos, linfócitos antígeno-específicos, fagócitos e, 
principalmente, pela produção das proteínas de fase aguda no fígado (Klasing, 
2007).  
 
2.2 Microbiota intestinal de frangos de corte 
A saúde intestinal está diretamente relacionada com o perfil da 
microbiota que interage com o hospedeiro regulando a eficiência absortiva, 
apresentando mecanismos antagônicos a bactérias patogênicas, reforçando a 
integridade intestinal e modulando a imunidade (Oviedo-Rondón et al., 2009; 
Pan e Yu 2014). Ao contrário do genoma do hospedeiro, que raramente é 
manipulado por intervenção xenobiótica, o microbioma é facilmente alterável, 
principalmente pela dieta, ingestão de antibióticos e infecção por agentes 
patogênicos (Day et al., 2015). 
Os microrganismos que compõe a microbiota intestinal estabelecem 
relações de cooperação e competição por nutrientes e locais de aderência no 
lúmen, estabelecendo equilíbrio da comunidade microbiana. No intestino 
delgado dos frangos predominam bactérias do gênero Lactobacillus, 
Clostridiaceae, Streptococcus e Enterococcus, ao contrário do que ocorre no 
ceco, onde predomina a família Clostridiaceae, seguida dos gêneros 
Fusobacterium, Lactobacillus e Bacteroides (Lu et al., 2003).  
Por outro lado, o aumento no número de Lactobacillus, geralmente, 
está associado com uma melhor saúde intestinal. No entanto, Torok et al. 
(2011), observaram que o pior desempenho está relacionado com o aumento L. 
salivarius, L. aviarius e L. crispatus no íleo de frangos. Segundo Guban et al. 
(2006), a espécie L. salivarius  pode estar associada ao pior desempenho em 
frangos por desconjugar os sais biliares prejudicando a emulsificação de 
gordura (Guban et al., 2006).  
Dentre os membros da família Clostridiaceae a espécie Clostridium 
perfringens é conhecida por ser um patógeno causador da enterite necrótica. 
Esta bactéria é um habitante normal do ceco, no entanto, quando o ambiente 
torna-se favorável há uma rápida proliferação, podendo estender-se para o 
intestino delgado, onde geralmente está em baixa concentração, levando à 
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enterite necrótica (Shojadoost et al., 2012). A população de C. perfringens no 
intestino delgado de aves saudáveis é normalmente 102 a 104 UFC/g de 
conteúdo intestinal; quando instaurada a enterite necrótica, a população fica 
em tono de 107 a 109 UFC / g de conteúdo intestinal (Shojadoost et al., 2012). 
Sabe-se que um dos fatores que favorece a proliferação desse patógeno é a 
coccidiose, por causar imunossupressão, danos na barreira da mucosa, 
aumento da produção de muco e aumento de proteínas plasmáticas, 
disponibilizando substrato para o crescimento do Clostridium perfringens 
(Kitessa et al., 2014). Entretanto, é importante destacar que nem todas as 
espécies do gênero Clostridium são consideradas patogênicas A espécie 
Clostridium butyricum é utilizada como probiótico melhorando o desempenho e 
a eficiência alimentar de frangos (Yang et al., 2012). Zhang et al. (2016), 
observaram que em frangos desafiados por  Escherichia coli, a utilização de  C. 
butyricum melhorou o ganho de peso e reduziu a população de E.coli.  Além 
disso, o Clostridium coccoide produz acido butírico e o C. cellulosi degrada a 
celulose melhorando a saúde intestinal, demonstrando que a presença do 
gênero Clostridium pode trazer benefícios ao desempenho animal (Rubio et al., 
2014; Stanley, 2012) . 
As bactérias comensais são importantes para o desenvolvimento e 
maturação da resposta imune inata (Muir et al., 2000; Brisbin et al., 2011). 
Estudos com mamíferos mostraram que bactérias comensais específicas têm 
um papel vital na indução de células imunes (Kogut, 2013). As bactérias 
pertencentes ao filo Bacteroidetes apresentam associação com o 
desenvolvimento de células T-helper produtoras de IL-17 (Mazmanian et al., 
2005). Por sua vez, o grupo Lactobacilos possui capacidade de ativar o sistema 
imunológico e aumentar a resistência a doenças, em parte através da liberação 
de peptídeos de baixo peso molecular que induzem ativação imune (Muir et al., 
2000) .  
A disbiose pode afetar a morfologia da parede intestinal e induzir 
reações imunes, ou ainda aumentar a população de bactérias patogênicas, 
induzindo a resposta imune e desviando a energia e os nutrientes do 
crescimento para a resposta inflamatória, aumentando assim a demanda para 
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a mantença (DiAngelo et al., 2009; Humphrey e Klasing, 2003). A resposta 
inflamatória é de extrema importância para a eliminação do patógeno (Kogut, 
2013). No entanto, se for descontrolada, essa ativação imune representa um 
risco de inflamação excessiva e danos intestinais, que por sua vez, podem 
prejudicar as funções digestivas do intestino (Brisbin et al., 2011). Além disso, a 
inflamação excessiva também pode causar distúrbios no metabolismo do 
hospedeiro (Kogut, 2013). Foi relatado que a microbiota comensal desempenha 
papéis importantes na manutenção da homeostase imune intestinal e na 
prevenção da inflamação intestinal (Lan et al., 2005). 
 
 
2.3 A coccidiose aviária 
A coccidiose aviária é uma doença intestinal causada por 
protozoários do gênero Eimeria que se multiplicam no intestino causando 
destruição tecidual e prejudicando a digestão e a absorção de nutrientes, 
resultando em diarreia aquosa ou hemorrágica (Berchieri Jr. et al., 2009). A 
Eimeria afeta espécies de animais de maneira específica, sendo que a E. 
acervulina, E. brunetti, E. máxima, E. mitis, E. praecox, E. necatrix e E. tenella 
possuem especificidade para aves doméstica. O sistema de produção intensiva 
com elevada densidade no interior dos galpões, propicia um ambiente favorável 
para o acúmulo de uma elevada quantidade de parasitas, bem como aumenta 
a facilidade de transmissão do parasita entre as aves (Shirley et al., 2007).  
Cada espécie de Eimeria possui características próprias quanto à 
prevalência, local de infecção, patogenicidade e imunogenicidade (Berchieri Jr. 
et al., 2009).  Comparando a E. tenella  com a E. máxima , a primeira é uma 
das mais patogênicas entre as sete espécies que infectam os frangos. Ela 
invade a mucosa cecal, causando inflamação e danos aos enterócitos. Possui 
curta duração, mas com sinais clínicos severos e mortalidade elevada, que 
ocorrem, em geral após o quinto dia de infecção. (Lillehoj et al., 2004). Kipper 
et al. (2013), realizaram uma meta-análise para verificar  as variações no 
desempenho produtivo que ocorreram em frangos desafiados com diferentes 
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espécies de Eimeira e observaram que o desafio não afetou o consumo de 
ração para aves infectadas com  E. acervulina e E. tenella.  No entanto, na 
infecção com ambas as espécies de Eimeria houve um menor ganho de peso, 
e uma pior conversão: para E. tenella esses decréscimos fora na ordem de 
10% e 49%, respectivamente. 
Alta mortalidade com coccidiose clínica com a coccidiose não é 
comum. Na maioria dos casos ocorre a infecção subclínica, o que dificulta o 
diagnostico da doença em um tempo hábil para começar um tratamento antes 
que ocorra a perda de desempenho. Durante a infecção subclínica, ocorre a 
piora na digestão e absorção de nutrientes, em virtude das lesões no trato 
gastrointestinal, e queda no desempenho (Cornelissen et al., 2009). Além 
disso, o desafio por coccidiose pode mudar drasticamente a comunidade 
bacteriana no intestino, diminuindo a diversidade microbiana e criando um 
ambiente favorável para disseminação de outros patógenos como a bactéria 
gram-positiva C. perfringens (Kley et al., 2012). O trabalho de Oviedo-Rondon 
et al (2010), mostrou que após o desafio por Eimeria spp. o perfil microbiano no 
íleo e no ceco foi alterado em 45 e 64%, respectivamente. No entanto, com a 
utilização de dietas suplementadas com uma mistura de fitogênicos, essa 
alteração foi de apenas 19 e 32%. 
 
   
2.3.1 Resposta imunológica contra coccidiose  
A infecção por Eimeria spp. induz uma resposta imune complexa ao 
hospedeiro,  porque o parasita exibe um ciclo de vida extracelular e intracelular 
Durante a fase inicial de infecção, o sistema imune inato do hospedeiro pode 
detectar e responder rapidamente à infecção do protozoário através dos 
receptores de reconhecimento padrão (Gazzinelli e Denkers, 2006). No 
entanto, a imunidade mediada por células, principalmente por linfócitos intra-
epiteliais (IELs) e linfócitos da lâmina própria, representam o principal 
componente da imunidade protetora contra a coccidiose aviária. Estudos com 
as principais espécies de Eimeria revelaram um papel essencial para o sistema 
imune inato e o mediado por células, tanto pela produção de citocinas como 
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por ataque citotóxico direto nas células afetadas (Yun et al., 2000; Laurent et 
al., 2001) 
Zhou et al. (2014), identificaram durante a infecção por E. tenella um 
aumento na expressão gênica de Toll-like receptor tipo ChTLR3, ChTLR15 e 
MyD88 no ceco. A maioria dos TRLs utilizam a proteína adaptadora 
denominada MyD88, responsável pela ativação dos três principais fatores de 
transcrição o MAPK, NF-kB e IRF3 que ativam os genes de quatro principais 
proteínas pro-inflamatórias IL-1, IL-6, IL-12, TNF-α  e IFN- γ  (Tizard, 2009). Já 
o IFN-γ desempenha um papel crítico na mediação de imunidade protetora 
contra parasitas Eimeria, estimulando macrófagos a produzir óxido nítrico, o 
que inibe a replicação de E. tenella no interior das células hospedeiras (Lillehoj 
e Choi, 1998). A expressão do gene de IFN-γ como resposta à infecção por 
Eimeria em frangos parece restrita ao local do intestino parasitado (Laurent et 
al., 2001). Assim, em aves inoculadas com E. tenella, a expressão de IFN-γ 
detectada por RT-qPCR aos 7 dias após inoculação esteve restrita ao ceco, 
enquanto que em aves inoculadas com E. maxima, foi detectada no jejuno e no 
íleo (Laurent et al., 2001). Por último, o TNF-α é estimulado pelos macrófagos e 
NF-ƙB. Frangos infectados com coccídias aumentam a expressão de TNF-α e 
quando tratados com anticorpos policlonais para TNF-α revertem a perda de 
peso causada pela coccidiose. Tal fato sugere que essa citocina esteja 
envolvida na fisiopatologia da coccidiose (Allen e Fetterer, 2002).  
 
2.4 Aditivos para a saúde intestinal 
 
Existe um grande interesse na produção animal em desenvolver aditivos 
alimentares com a capacidade de melhorar o desempenho, controlar os 
patógenos e modular a microbiota intestinal. Neste sentido, os antibióticos são 
utilizados como promotores de crescimento por inibir o crescimento bacteriano, 
a infecção subclínica endêmica, reduzindo assim os gastos metabólicos do 
sistema imunitário (inato) também; melhoram a absorção e utilização de 
nutrientes, pois a parede intestinal dos animais alimentados com antibióticos 
promotores de crescimento torna-se mais fina (Niewold, 2007).  
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No entanto, os resíduos encontrados na carne e a resistência aos 
antibióticos podem ter consequências críticas para o meio ambiente, segurança 
alimentar, bem-estar dos animais e aceitabilidade por parte do consumidor. O 
aumento do interesse dos consumidores nessas questões e das 
regulamentações governamentais relativas a práticas prudentes de uso de 
antibióticos estimularam pesquisas com o intuito de encontrar substâncias 
alternativas (Roberts et al., 2015). Para buscar substâncias alternativas é 
preciso ir além dos resultados de desempenho animal e entender o impacto do 
produto no ecossistema do intestino. Para isso é necessário avaliar a interação 
entre os fatores que o compõem o sistema microbiota x nutrição x sistema 
imune, possibilitando o desenvolvimento de ferramentas para modular-loe 
melhorar o desempenho animal. Algumas substâncias já foram estudadas e 
incluem probióticos, prebióticos, simbióticos, enzimas, fitogênicos e ácidos 
graxos voláteis (Sugiharto, 2016; Roberts et al., 2015). 
 
2.4.1 Líquido da casca da castanha e óleo de mamona  
 
O líquido da casca da castanha do caju (LCCC) é um subproduto que 
representa aproximadamente 25% do peso da castanha. Diferentes processos 
podem ser empregados para a obtenção do LCCC: extração a frio (prensas), 
extração por solvente e processo térmico-mecânico. O LCC proveniente da 
extração com solventes é constituído principalmente de ácido anacárdico (60-
65%), cardol (15-20%), cardanol (10%) e traços de 2-metil cardanol (KUMAR et 
al., 2002). Quando proveniente do processo térmico-mecânico o LCC é 
constituído por cardanol (60-65%), cardol (15 -20%), material polimérico (10%) 
e traços do 2-metil cardol. Isso acontece porque o ácido anacárdico é 
termicamente instável e é facilmente descarboxilado durante o processo de 
extração por aquecimento, quando é transformado em cardanol (Costa et al., 
2004). 
Lopez et al. (2012), estudando níveis crescentes de LCC extraído com o 
processo térmico-mecânico  na dieta de frangos (0,1; 0,2; 0,3; e 0,4 ml de 
LCC.kg-1de ração) e comparando com um promotor de crescimento 
(virginiamicina) observaram que o LCC apresentou desempenho e rendimento 
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de abate semelhantes ao promotor de crescimento, além de reduzir a 
concentração de E. coli no conteúdo intestinal em aves não desafiadas.  
Segundo Abbas et al. (2012), os componentes do líquido da casca de 
castanha de caju têm ação semelhante a um ionóforo monovalente, causando 
danos à membrana celular da bactéria. A atividade antimicrobiana do líquido 
está associada ao número de terpenóides e de compostos fenólicos presente 
na sua estrutura, com ação contra bactérias gram-positivas (Kanehashi et al., 
2015). Além disso, o LCCC possui atividade anfipática, principalmente o 
cardanol e tende a se distribuir na interface dos fluidos e assim reduzir a tensão 
interfacial das moléculas, atuando assim como um agente surfactante (Nitschke 
e Pastore, 2002).   
O óleo de mamona é um óleo funcional, composto majoritariamente 
(90%) de ácido ricinoleico conhecido por sua ação laxativa (Vieira et al., 2001).  
O ácido ricinoleico exerce efeito antimicrobiano desnaturando e coagulando as 
proteínas da parede celular bacteriana. O grupamento éster que compõe a 
molécula de ácido ricinoleico favorece a hidrólise por esterases plasmáticas 
que formam álcool e inibem a enzima transpeptidadase responsável pela 
síntese de peptídeoglicanos, presentes principalmente na parede das bactérias 
gram-positivas (Guimarães et al., 2010). Assim o óleo de mamona pode atuar 
como um inibidor da síntese da membrana celular.  
Em função das propriedades químicas descritas acima, foi desenvolvida 
uma mistura comercial do líquido da casca de castanha de caju e do óleo de 
mamona comercialmente chamada de Essential® (Essential, US Patent N°. 
8,377,485 B2: Oligo Basics Agroind. Ltda., Rua Sérgio Gasparetto 503, 
Cascavel, PR-CEP, Brazil). Os compostos ativos do Essential são o cardanol, 
acido ricinoleico e o cardol, respectivamente nas concentrações de 200g/kg, 90 
g/kg e 40g/kg. Avaliando essa mistura comercial na dieta de frangos de corte 
desafiados por coccidiose, observou-se um aumento no ganho de peso e uma 
melhoria na conversão alimentar (Murakami et al., 2014), além de uma melhora 
de 100 kcal de energia metabolizável quando comparada com a dieta controle 
(Bess et al., 2012; Murakami et al., 2014). Esse aumento na disponibilidade de 
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energia pode estar relacionado com os efeitos antimicrobianos dos óleos 
funcionais (Bess et al., 2012). 
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3. HIPÓTESES E OBJETIVOS 
 
3.1 Hipóteses 
 
 A mistura do líquido da casca da castanha de caju e do óleo de 
mamona aumenta o desempenho de frangos de corte desafiados 
por algum agente inflamatório, nesse experimento representado 
pela coccidiose. 
 A mistura do líquido da casca da castanha de caju e do óleo de 
mamona tem efeito anti-inflamatório, minimizando a perda de 
desempenho causada por uma reação inflamatória. 
 A mistura do líquido da casca da castanha de caju e do óleo de 
mamona atua como um modulador da microbiota intestinal em 
frangos desafiados por coccidiose.  
 
 
3.2 Objetivos 
 
3.2.1 Geral 
 
Avaliar a mistura comercial do líquido da casca de castanha de caju 
e do óleo de mamona (Essential, Oligo Basics Agroind. Ltda., Cascavel, Brasil) 
no desempenho, na microbiota e no sistema imune de frangos de corte 
desafiados ou não por coccidiose. 
 
 
3.2.2 Específicos 
 
 Avaliar a mistura do óleo da casca da castanha de caju e do óleo 
de mamona como promotor de crescimento em frangos de corte. 
 Avaliar a atividade anti-inflamatória e antimicrobiana da mistura de 
óleos. 
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 Analisar a microbiota intestinal de frangos de corte suplementados 
com a mistura de óleos após o desafio por coccidiose. 
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ABSTRACT 
The aim of the study was to evaluate a cashew nut shell oil and castor oil blend 
commercial (CNSL - Castor oil) effect on performance and microbiota of broiler 
chickens challenged or not with coccidiosis. A total of 864 one - day - old male chicks 
(Cobb) were randomly distributed in 6 treatments (8 pen / treatment and 18 chicks / 
pen) in a 3 x 2 factorial with 3 additives: control (non- additive), 100 ppm of sodium 
monensin or 0.15% Essential, and 2 challenge levels at 14 days of age: 
unchallenged or inoculated by gavage with 1mL of solution containing oocysts 
sporulated with Eimeria tenella, Eimeria acervulina and Eimeria maxima. In the 
period before the challenge and for birds that were not challenged, no differences in 
the productive performance among treatments were observed (P > 0.05). After seven 
days of challenge, birds receiving monensin presented better performance compared 
to the positive control group (non-additive and challenge) or CNSL- Castor oil (P > 
0.05). However, 14 days after the challenge, birds supplemented with CNSL- Castor 
oil presented higher weight gain and better feed conversion (P > 0.05), without 
altering feed intake (P > 0.05). In the accumulated period (1-42 days of age) the live 
weight, weight gain and feed intake did not differ between the CNSL- Castor oiland 
monensin groups, and these were larger than the positive control. The challenged 
birds increased the number of Lactobacillus spp. and Clostridium perfringens copies 
(P < 0.05). CNSL- Castor oil supplementation reduced Clostridium cluster XIV, 
Clostridium perfringens and S. aureus, compared with monensin and control groups 
(P > 0.05). In addition, Essential presented higher number of Lactobacillus spp. 
copies, followed by monensin and positive control groups (P > 0.05). Thus, monensin 
and CNSL - Castor oil were effective in minimizing the impact of coccidiosis at 
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different times. While monensin acts as an antimicrobial, CNSL- Castor oil acts as an 
intestinal microbiota modulator with antimicrobial action against gram-positive 
bacteria, mainly C. perfringens and S. aureus. 
Key Words: Coccidiosis, Functional oils, Gut health, Microbiota, Monensin 
 
INTRODUCTION 
The microbiota evolved with the host as a mutualistic partner, and its balance 
is linked to the abundance and diversity of species. However, dysbiosis can cause a 
number of disorders affecting the intestinal wall morphology, reducing diversity by the 
increase of pathogenic bacteria population, inducing the immune response, diverting 
energy and nutrients from the growth to the inflammatory response and, 
consequently, reducing  performance (Kogut, et al., 2013, DiAngelo et al., 2009). In 
this context, there is great interest in developing food additives with the ability to 
improve performance, control pathogens and modulate intestinal microbiota. The 
phytogenetics have presented interesting results improving intestinal health and 
modulating the microbiota as additives for animal production (Kim et al., 2013; Abdel-
Wareth et al., 2012; Kley et al., 2012; Oviedo-Rondón et al., 2010; Hume et al., 2006; 
Oviedo-Rondón et al., 2006). 
 Some factors like age, diet, food additives and the presence of pathogens are 
known to alter the intestinal microbiota. Coccidiosis challenge can drastically change 
the bacterial community in the gut, reducing microbial diversity (Kley et al., 2012) and 
creating a favorable environment for pathogens dissemination such as gram-positive 
bacteria Clostridium perfringens (Baba et al., 1997). Oviedo-Rondón et al. (2010) 
observed that the microbial profile in the ileum and cecum was altered in 45 and 
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64%, after Eimeria spp. challenge. However, using diets supplemented with 
phytogenic blend, this change was only 19% and 32%. 
 Within the phytogenic category, the functional oils are defined as oils that have 
an action beyond nutritional value (Murakami et al., 2014). Castor oil is a functional 
oil, composed of 90% ricinoleic acid (Dabdoub and Bronzel, 2007), known for its 
laxative action (Vieira et al., 2001). Also has an antimicrobial action: the ester 
derivatives break the glycosidic bonds of the peptideoglycans present, mainly, in the 
wall of the gram-positive bacteria (Oliveira et al., 2005; Guimarães et al., 2010). 
 The cashew nuts liquid is mainly composed of cardanol, cardol and anacardic 
acid (Mazzetto et al., 2009). The antimicrobial activity of the liquid is associated with 
the number of terpenoids and phenolic compounds present in its structure 
(Kanehashi et al., 2015), acting against gram-positive bacteria (Himejina and Kubo 
1991, Parasa et al., 2011). In vitro studies observed that both functional oils had 
mechanisms of action of an ionophore (Maenz and Forsyth, 1982; Vieira et al., 2001; 
Toyomizu et al., 2003). 
 Due to its chemical properties, a blend of cashew shell liquid and castor oil 
was developed and commercially called Essential® (Essential, US Patent N°. 
8,377,485 B2: Oligo Basics Agroind. Ltda., Rua Sérgio Gasparetto 503, Cascavel, 
PR-CEP, Brazil). Evaluating this commercial blend in the diet of broilers challenged 
with coccidiosis, increasing in weight gain and an improvement in feed conversion 
were observed (Murakami et al., 2014), as well as an improvement in a 100 kcal of 
ME (Bess et al., 2012 and Murakami et al., 2014). This increase in energy availability 
may be associated to the functional oils antimicrobial effects (Bess et al., 2012). 
However, there is no literature demonstrating its antimicrobial action in vivo. 
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 The aim of the present study was to evaluate the effect of cashew shell liquid 
and castor oil blend on performance and microbiota of broilers challenged with 
coccidiosis, comparing to monensin ionophore. 
 
MATERIALS AND METHODS 
The Institutional Animal Care and Use Committee at Federal University of Rio 
Grande do Sul reviewed and approved the protocol number 29814 used in the 
present study. 
Animals and diets  
 A total of 864 one-day-old male chicks (Cobb 500) were obtained in a 
commercial hatchery and housed in two identical experimental rooms, for challenged 
and unchallenged birds, thus avoiding cross-contamination. The rooms were 
composed of 48 pens with an initial density of 18 birds per pen. The nutritional 
program consisted of three diets: pre-starter (1 to 7 days), starter (8 to 21 days) and 
grower (22 to 28 days) based on the nutritional requirements recommended by the 
Brazilian Tables of Pigs and Swine (Rostagno et al., 2011). The nutritional 
composition was the same for all treatments, varying only the additive used. 
 Every week broilers were weighed, feed intake was measured and in the 
calculation of feed conversion, the weight of dead bird was considered (Sakomura 
and Rostagno 2016). 
Experimental design 
 The experimental design was completely randomized in a 3x2 factorial 
arrangement: food additives (basal diet, 100 ppm sodium monensin or 0.15% Castor 
oil-CNLS) and sanitary challenge (challenged or unchallenged with coccidiosis). Both 
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food additives, Essential and monensin sodium, were introduced by replacing inert 
(kaolin) in the basal diet at all phases. 
Challenge and sample collection 
 At 14 days of age, 1mL of sporulated oocysts of E. tenella (10x10³), E. 
acervulina (200x10³) and E. maxima (80x10³) was inoculated by gavage. The oocyts 
were acquired at the Laboratório de Biologia Molecular de Coccídias (University of 
São Paulo/ Brazil). Unchallenged chickens received 1mL of saline, providing the 
same management stress. 
 After 7 and 14 days of oocysts inoculation (21 and 28 days of age), three 
average weight birds from each replicate were euthanized by cervical dislocation and 
evaluated for lesion score by Eimeria spp. Lesions were ranked from 0 (absence of 
macroscopic lesions) to 4 (presence of severe macroscopic lesions), according to the 
method described by Johnson and Reid (1970). 
 At 28 days of age, the same birds euthanized for the lesion score,  were used 
to collect the intestinal contents. A portion of 10 cm of the duodenum segments (from 
pylorus exit to the end of the descending duodenal loop), jejunum (descending 
duodenal loop to the Meckel's diverticulum) and ileum (diverticulum to ileocecal 
insertion) were removed and immediately stored at -20 ° C . 
DNA extraction 
 The intestinal contents were separated and the concentrated bacterial fraction 
was obtained according to the procedure proposed by Apajalahti et al. (1998). The 
DNA was extracted with the PowerFecal ™ DNA Isolation Kit (MoBio, UK), following 
the manufacturers recommendations. After extraction, its quality was verified using a 
NanoDrop 2000 (Invitrogem) and quantified using Qubit 3.0 (Invitrogen). The DNA 
obtained was diluted to a concentration of 2 ng / ul. 
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 q-PCR absolute curve 
 The sequence of primers selected, the size and annealing temperature are 
shown in Table 2. The reactions were conducted on the StepOnePlus ™ Real-Time 
PCR System (Applied Biosystems), in a final volume of 15 μL, containing 2,0 μL of 
PCR buffer 10x; 1,6 μL of MgCl2 [50mM] 0,5 μL of each primer [10 μM]; 0,2 μL of 
dNTP [(5 mM); 2,0 μL Syber green (1x), 0,05 μL Platinum® Taq DNA Polymerase 
[5U/ μL] 5 μL of DNA. and ultra pure water to complete the volume. The conditions 
for q-PCR were 94 ° C for 5min, 35 cycles at 94 ° C for 30s, annealing temperature 
specific for each oligonucleotide pair (Table 2) for 30s and 72 ° C for 30s. After the 
amplification cycles, the dissociation curve of the amplification products was 
performed by raising the temperature from 60 to 95 °C to obtain the dissociation 
curve of the reaction products. 
 An ATCC bacterium according to the primer (Table 1) was used to construct 
the standard curve. The bacteria were cultured in specific media without antibiotics. 
Bacterial genomic DNA was extracted using PureLink® Genomic DNA Kits 
(Invitrogen). Serial dilutions of gene copies were from 3x109 to 3x102 on each plate. 
The threshold was adjusted for each standard curve to achieve an amplification 
efficiency close to 100%. The CT (cycle threshold) was determined for each sample 
and compared to the standard curve to determine the number of copies in 2 ng of 
genomic DNA. The number of copies per gram of intestinal contents was calculated 
taking into account the initial mass of the starting material, extraction yield and the 
DNA dilution. 
Statistical analysis 
 The number of gene copies was transformed into log10 to obtain a normal 
distribution. An ANOVA of the factorial arrangement was performed, including the 
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challenge effects, additives and their interactions for all variables of performance, 
lesion score and microbiota. Means were compared by LSmeans when significant 
differences were found. The GLM procedure of the statistical package SAS, version 
9.0 (SAS Institute 2002) was used. 
 
RESULTS 
Growth performance 
 In the period before the challenge and for the unchallenged birds, there was 
no statistical difference in performance among treatments for all periods evaluated. 
Mortality was less than 1% after challenge (data not shown / supplementary 
material). 
 Animal performance was negatively affected by coccidiosis in the week after 
the challenge (14 to 21 days of age), decreasing BWG by 49% and worsening FCR 
by 58% (P < 0.0001). In the second week after the challenge (21 to 28 days of age) 
the negative challenge effect was less intense, 26% lower BWG and 20% worse FCR 
(Table 2). The lowest performance of the challenged birds was also observed in the 
total rearing period (1 to 42 days of age-Table 3), with lower weight gain, feed intake 
and worse feed conversion. The challenged birds showed 17% live weight reduction 
at 42 days of age. 
 In the week following the challenge (14 to 21 days of age) there was an 
interaction between additives and challenge for all variables analyzed (Table 3). In 
the challenged birds, weight gain and feed intake were higher and feed conversion 
was better in the monensin group, and no differences were seen between the other 
groups (P < 0.05). Two weeks after the challenge (21 to 28 days of age), birds 
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supplemented with Castor oil-CNLS presented greater weight gain (P < 0.05) and 
better feed conversion (P < 0.05) than the other treatments. In the accumulated 
period (1 to 42 days of age), positive control group presented lower live weight than 
the other groups (P < 0.01), which showed no differences between them, 
demonstrating that monensin and CNSL- Castor oil compensated the coccidiosis 
negative effect. No interaction for feed conversion was observed. 
   Analyzing the factors individually, challenge decreased feed conversion and, 
regardless of the challenge, monensin presented better feed conversion when 
compared to control; Castor oil-CNLS was intermediate, but not differ for control an 
monensin. 
Lesion score 
 In the first week after infection, broilers receiving monensin had a lower lesion 
score for E. acervulina compared to the other groups (P < 0.0001). In the following 
week, the broilers with CNSL- Castor oil had a lower lesion score for E. tenella (P < 
0.0480). There was no difference (P > 0.05) among groups for lesion score of E. 
maximus in any week evaluated (Figure 1). 
Microbiota modulation using monensin or CNSL- Castor oil 
 There was interaction among the factors for bacterial domain (total bacteria 
number), Lactobacillus spp., Clostridium cluster XIV, C. perfringens, E. coli and S. 
aureus (P < 0.05) (Tables 4 and 5). In the challenged birds, monensin reduced 
bacterial domain and E. coli compared to the other groups. CNSL- Castor oil reduced 
copy number of Clostridium cluster XIV, C. perfringens and S. aureus, monensin and 
positive control did not differ. In the unchallenged birds bacterial domain, Clostridium 
cluster XIV and S. aureus did not presented statistical difference among groups. 
Lactobacillus spp. copy number was lower for the positive control, followed by 
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monensin and CNSL- Castor oil. Both monensin and CNSL- Castor oil reduced C. 
perfringens and E.coli. copy number. 
 Regardless of the challenge, the positive control group presented more 
Bifidobacterium spp (P < 0.05) copies than CNSL- Castor oil, and monensin group 
was intermediate. The copy number of Enterococcus spp. genus was higher for 
positive control group and lower for monensin and CNSL- Castor oil that did not 
differ. 
 
DISCUSSION 
 The present study was conducted based on recent studies using coccidiosis 
challenge (Bortoluzzi et al., 2015; Cox et al., 2010; Kim et al., 2011; Orengo et al., 
2012; Scheurer et al., 2013). In this study, the challenge presented irrelevant 
mortality (<1%). However, it was enough to decrease animal performance throughout 
the evaluation period. 
 Anti-coccidial drugs have high efficiency in reducing losses caused by 
coccidiosis infection. On the other hand, intensive use may stimulate parasite 
resistance (Chapman et al., 2010). Some phytogenetics studied have achieved a 
recovery in performance similar to the drugs (Bess et al., 2012; Kley et al., 2012; 
Mohiti-Asli and Ghanaatparast-Rashti, 2015). In this study, the use of monensin 
improved performance in the week immediately post challenge. However, CNSL- 
Castor oil provided late but consistent compensatory gains, noting that at 42 days of 
age, both groups did not differ in weight gain, feed intake and live weight. 
 The worst performance during coccidiosis challenge is associated with the 
reduction in the intestinal absorption area, nutrient absorption deficit and 
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inflammation caused in the first week after the challenge (Giannenas et al., 2012, 
Laurent et al., 2001, Cornelissen et al., 2009, Cox et al., 2010). It is possible to 
speculate that CNSL- Castor oil has lower anticoccidial action than monensin, but its 
mechanism of action may be associated with recovery of intestinal health after the 
inflammation peak, allowing a similar growth performance to the ionophore in the 
accumulated period (1 -42 days).  
 Intestinal health is directly related to the profile of the microbiota that interacts 
with the host. The microbiota regulates the absorptive efficiency, presents 
antagonistic mechanisms to pathogenic bacteria, enhances intestinal integrity and 
modulates the immunity (oviedo-Rondón, 2009; Pan & Yu 2013). The results show 
that coccidiosis challenge did not significantly affect the total number of bacteria, but 
change the microbiota profile, increasing the population of Lactobacillus spp., 
Clostridium cluster XIV, C. perfringens and S. aureus. Some studies show that after 
coccidiosis challenge there is an increase of Clostridium bacteria and lactic acid 
fermenters such as Lactobacillus (Klim et al. 2015; Stanley et al. 2014; Enberg et al. 
2012; Kley et al. 2012; M’sadeq et al. 2012). This is due to the increase in the 
amount of mucus and the presence of proteins from the cells damaged by the 
coccidia (Collier et al., 2008), serving as a substrate for beneficial and pathogenic 
bacteria (Deplancke and Gaskins, 2001).   
Broilers that received monensin or CNSL- Castor oil and were unchallenged 
showed Lactobacillus increase, and C.perfringens and E. coli decrease, when 
compared to the control group. Lactobacillus have beneficial characteristics for the 
host, such as modulating the immune system and antagonizing pathogenic bacteria 
(Yousaf et al., 2010; Klose et al., 2010; Servin et al., 2004). They are usually 
considered as a beneficial group, however the presence of three species of 
  
38 
 
 
Lactobacillus, L. salivarius, L. aviarius and L. crispatus, may be associated with the 
worst performance in broilers, because they deplete the bile salts and impair fat 
emulsification (Guban et al., 2006). 
 Monensin is an ionophore known for its coccidiostatic, antimicrobial and 
growth promoting action (Huyben et al., 2001). Challenged birds, compared with the 
unchallenged receiving monensin, showed total number of bacteria reduction and 
increase Clostridium cluster XVI, C. perfringens and S. aureus increase. This change 
was similar to the positive control, showing that monensin, even causing a reduction 
in the total number of bacteria, provided a profile similar to the challenged control 
group. A quantitative and qualitative change in the microbiota profile is characteristic 
of dysbiosis process, in this case caused by coccidiosis. Dysbiosis is defined as an 
undesirable microbiota alteration, resulting in an imbalance between beneficial and 
pathogenic bacteria, and it may negatively affect animal performance (Ducatelle et 
al., 2014). 
 Studies suggest that phytogenic additives use has shown positive results in 
intestinal microbiota modulation even in the presence of a coccidiosis challenge 
(Abdel-Wareth et al., 2012; Hume et al., 2006; Kim et al., 2013; Kley et al., 2012; 
Oviedo-Rondón et al., 2006; Oviedo-Rondón et al., 2010). In this study, CNSL- 
Castor oil appears as beneficial modulator of the intestinal microbiota, because it did 
not caused differences for Lactobacillus spp., Clostridium ssp., Clostridium 
perfringens and S. aureus population in challenged broilers, although it did not 
reduce the total bacteria domain. This balance in the microbiota may have aided in 
the performance recovery after challenge. The microbiota composition may be 
directly associated to the best animal performance, but it is not entirely clear how this 
relationship works (Stanley et al., 2013). In this study, Enterococcus genus was 
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reduced in challenged animals receiving the functional oil blend. Some species of 
this genus are pathogenic; for example, Enterococcus cecorum is related to bone 
diseases, such as osteomyelitis (Kense and Landman, 2011). In addition, 
Enterococcus spp. are opportunistic and can spread rapidly when dysbiosis occurs 
(Cao et al., 2013). Lunedo et al. (2014) associated a worse feed conversion in 
chickens receiving low tannin sorghum with the increase of Enterococcus genus and 
Enterobacteriaceae family in the ileum. 
In this study, it was possible to observe an increase in S. aureus species copy 
number in the challenged broilers, except for the group that received the functional oil 
blend. In general, the genus Staphylococcus spp. is a normal habitant of the skin and 
mucous membranes, also considered opportunistic (Jonsson and Wadstrom 1993). 
In poultry, S.aureus is the most common species that cause disease. Its rapid spread 
in the intestine occurs when immune resistance is low due to infection by other 
pathogens, immunosuppression and skin or mucosal lesions, causing diseases such 
as salpingitis, folliculitis, bursitis, gangrenous dermatitis and cellulitis (Ferreira and 
Ferreira, 2009). 
The results of this study show that the functional oil blend has an action 
against gram-positive bacteria acting as a modulator of the intestinal microbiota. 
According to Abbas et al. (2002), the liquid cashew nutshell components, cardoles 
and anacardic acid have a similar action than a monovalent ionophore, causing 
damage to the bacterial cell membrane. Moreover, ricinoleic acid has antimicrobial 
effect denaturing and coagulating proteins of the bacterial cell wall. The ester group 
that composes the ricinoleic acid molecule favors hydrolysis by plasma esterase that 
form alcohol and inhibit the transpeptidase enzyme, responsible for the peptide 
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glycols synthesis (Guimarães et al., 2010). Thus, castor oil may act as an inhibitor of 
cell membrane synthesis. 
 The functional oils blend improved the performance of coccidiosis-challenged 
broilers in the second week, resulting in similar performance to those receiving  the 
ionophore monensin. The blend showed to be a good option in a coccidiosis 
challenge, acting as a modulator of the intestinal microbiota, with antimicrobial action 
against gram-positive bacteria, mainly C. perfringens and S. aureus. 
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Table 1. Ingredient formulas and chemical composition of experimental diets 
according to the rearing period 
Ingredients (%) 
Pre Starter 
(1-7 d) 
Starter 
(8- 21d) 
Grower 
(22- 42d) 
Corn 538.55 571.05 597.75 
Soybean Meal 384.60 354.60 321.10 
Vegetal Oil 31.80 33.30 43.00 
Dicalcium Phosphate 19.00 16.60 16.30 
Limestone 10.10 10.10 7.80 
Salt 5.10 4.80 4.60 
L-Lys HCl 3.00 2.50 2.70 
DL-Met 3.70 3.20 3.00 
L-Tre 1.20 0.80 0.70 
Vit-min Premix ¹ 1.05 1.05 1.05 
Choline Chloride 0.40 0.50 0.50 
Inert/Monensin/CNSL-
Castor oil ² 
1.50 1.50 1.50 
Total (kg) 1000.00 1000.00 1000.00 
Calculated composition       
Metabolizable Energy 
(Kcal/kg) 
3000 3050 3150 
Crude Protein (g/kg) 222.0 210.0 196.9 
Calcium  (g/kg) 9.2 8.6 7.6 
AvailableP (g/kg) 4.7 4.2 4.1 
Digestible P (g/kg) 3.9 3.6 3.5 
Potassium (g/kg) 8.6 8.1 7.6 
Sodium (g/kg) 2.2 2.1 2.0 
Chlorine (g/kg) 3.5 3.4 3.2 
Dig. Lysine (g/kg) 13.2 2.2 1.5 
Dig. Methionine (g/kg)                6.5 5.9 5.6 
Dig. Met+Cys (g/kg) 9.5 8.8 8.3 
Dig. Threonine (g/kg) 8.6 7.9 7.3 
Dig. Tryptophan (g/kg) 2.5 2.3 2.2 
Choline (mg/kg) 1550 1550 1450 
(Na+K)-Cl (mEq/kg)3 216.91 202.59 191.1 
1 Composition (per kg): 150000 mg of Mn, 100000 mg of Zn, 80000 mg of Fe, 15000 
mg of Cu, 1200 mg of I, 700 mg of Se,  23200000 UI of vitamin A, 5600000 UI of 
vitamin D, 52000 mg of vitamin K, 6000 mg of vitamin B1, 18000 mg of vitamin B2, 
9000 mg of vitamin B6, 132000 mg of niacin, 44000 mg of pantothenic acic, 2400 mg 
of folic acid, 200000 μg of biotin, 40000 μg of vitamin B12. 
² At all phases addition varied according to the treatment (1.50 g / kg of kaolin or 
CNSL- Castor oil or 0.250g / kg monensin + 1.25 g / kg of kaolin). ³ Electrolytic 
balance.
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Table 2. Target gene, annealing temperature (TA °C), base pairs and the ATCC bacterium used for the standard curve, primer 
sequence, and the reference of the groups and bacterial species studied 
Microorganisms   
Target 
Gene 
TAºC 
Amp 
(pb)  
 ATCC control Sequence (5' 3')  References 
Bacteria domain  16S 60 200 E. coli (10536) 
F: CGGYCCAGACTCCTACGGG  
Wise et al. (2007) 
R: TTACCGCGGCTGCTGGCAC  
Escherichia coli 16S 56 475 E. coli (10536) 
F: CCTACGGGAGGCAGCAGT  
Chiang et al. (2006) 
R: CGTTTACGGCGTGGACTAC  
Lactobacillus grup  16S 58 341 L. plantarum (8014) 
F: CACCGCTACACATGGAG  
Wise et al. (2007) 
R: AGCAGTAGGGAATCTTCCA  
Staphylococcus aureus nuc 60 279 S. aureus (4163) 
 F: GCGATTGATGGTGATACGGTT  
Rinttila et al. (2004a) 
R: AGCCAAGCCTTGACGAACTAAAGC  
Salmonella enteric invA 58 195 S. choleraesuis (10708) 
F: ATTTCAATGGGAACTCTGCC  
Zhang et al. (2009) 
R: ATCGAGATCGCCAATCAGTC  
Clostridium cluster XIV  16S 60 116 C. perfringes (13124) 
F:ACTCCTACGGGAGGCAGC 
Louie et al. (2012) 
R:GCTTCTTAGTCARGTACCG 
Clostridium perfringens 16S 56 120 C. perfringes (13124) 
F: ATGCAAGTCGAGCGA(G/T)G  
Rinttila et al. (2004) 
R: TATGCGGTATTAATCT(C/T)CCTTT 
Bifidobacterium spp. 16S 58 437 B. animalis (27672) 
F: GGGTGGTAATGCCGGATG  
Bartosh et al. (2005) 
R TAAGCCATGGACTTTCACACC  
Enterococcus spp. 16S 50 124 E. faecalis (29212) 
F: GAGAATGATGGAGGTAGAGC 
Lehner et al. (2005) 
R: GACTACGGATCTTATCACTC 
4
6
 
  
47 
 
 
Table 3. Feed intake (FI), weight gain (WG) and feed conversion ratio (FCR) of unchallenged (UD) and challenged (CD) broilers in 
the period of 14 – 21days and 21 - 28 days of age  
 
 
1
Essential (US Patent N°. 8,377,485; Oligo Basics Ind. Ltda., Cascavel, Paraná, Brazil). ² Probabilities: *** P <0.001, ** P <0.05 and ns: not 
significant; Means with different letters differ statically by LSMEANS, lower case in the column and uppercase in the row within the same 
variable. ² SEM: standard error of the mean 
 
 
 
 
 
 
Treatments 
14 - 21 d   21-28 d 
FI 
 
WG 
 
FCR 
 
FI WG 
 
FCR 
UD CD   UD CD   UD CD   UD CD UD CD   UD CD 
Challenge 
 
643 A 486 B 
 
419 A 215 B 
 
1.54 A 2.43 B 
 
870 A 754 B 536 A 396 B 
 
1,63 B 1,95 A 
Interaction 
Control 644 Aa 445 Bb 
 
422 Aa 175 Bb 
 
1.52 Aa 2.59 Bb 
 
847 A 741 B 518 Aa 357 Bb 
 
1,63 Ba 2,12 Aa 
Monensin 621 Aa 531 Ba 
 
415  Aa 296 Ba 
 
1.52 Aa 1.82 Ba 
 
887 A 741 B 551 Aa 374 Bb 
 
1,61 Ba 2,01 Aa 
CNSL- Castor oil ¹ 653 Aa 481 Bb 
 
422  Aa 174 Bb 
 
1.55 Aa 2.86 Bb 
 
878 A 780 B 540 Aa 457 Ba 
 
1,64 Ba 1,71 Ab 
Additive 
Control 545 
 
298.22 b 
 
2.06 a 
 
794 437 b 
 
1.88 a 
Monensin 581 
 
355.25 a 
 
1.67 b 
 
814 462 b 
 
1.81 a 
CNSL- Castor oil 567 
 
297.62 b 
 
2.21 a 
 
829 499 a 
 
1.68 b 
 Probability² 
 Challenge *** 
 
*** 
 
*** 
 
*** *** 
 
*** 
 Additive * Challenge ** 
 
*** 
 
*** 
 
ns ** 
 
*** 
Additive ns 
 
*** 
 
*** 
 
ns ** 
 
*** 
SEM  12.61  13.32  0.1   15.29 19.92  0.04 
4
7
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Table 4.  Body weight (BW), feed intake (FI), weight gain (WG) and feed convertion 
ratio (FCR) of unchallenged (UD) and challenged (CD) broiles in the period of 1- 42 
days of age 
Treatments 
BW (g)   FI (g)   WG (g)   FCR 
UD CD   UD ND   UD ND   UD ND 
Challenge 
 
2860 A 2373 B 
 
4539 A 3964 B 
 
2816 A 2330 B 
 
1,61 B 1,73 A 
Interaction 
Control 2868 Aa 2267 Bb 
 
4597 Aa 3848 Bb 
 
2824 Aa  2225 Ba 
 
1,63 1,73 
Monensin 2873 Aa 2416 Ba 
 
4497 Aa 4038 Ba 
 
2829 Aa 2393 Bb 
 
1,59 1,69 
CNSL- Castor oil¹ 2879 Aa 2435 Ba 
 
4576 Aa 4088 Ba 
 
2836 Aa 2372 Bb 
 
1.62 1,72 
Additive 
Control 2568 b 
 
4223 
 
2525 
 
1.69 a 
Monensin 2654 a 
 
4267 
 
2611 
 
1.62 b 
CNSL- Castor oil ¹ 2628 a 
 
4332 
 
2584 
 
1.67 ab 
Probability 
 Challenge *** 
 
*** 
 
*** 
 
** 
 Additive * 
Challenge 
** 
 
** 
 
** 
 
ns 
Additive ** 
 
ns 
 
ns 
 
** 
SEM²  44.40   42.28   445.578    0.036 
1
Essential (US Patent N°. 8,377,485; Oligo Basics Ind. Ltda., Cascavel, Paraná, Brazil). ² Probabilities: 
*** P <0.001, ** P <0.05 and ns: not significant; ²SEM: standard error of the mean. Means with 
different letters differ statically by LSMEANS, lowercase in the column and uppercase in the row within 
the same variable 
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Figure 1. Lesion score in coccidiosis challenged broilers at 21 (A) and 28 (B) 
days of age - 7 and 14 days after challenge. ¹ Essential (US Patent N°. 
8,377,485; Oligo Basics Ind. Ltda., Cascavel, Paraná, Brazil). Means with 
different letters differ statically by LSMeans 
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Table 5. Total bacteria copy number¹ (Bacteria Domain), Lactobacillus group, Bifidobacterium and Enterococcus genus and 
Clostridium group in the intestinal contents of broilers 14 days after challenge with coccidiosis 
 
 
¹ log10 copy number of 16S RNA gene in 1 gram of intestinal contents. UD: unchallenged broilers, CD: broilers challenged with coccidiosis.  ¹ Essential (US 
Patent N°. 8,377,485; Oligo Basics Ind. Ltda., Cascavel, Paraná, Brazil).SEM: Standard Error of the Mean. Means with different letters differ statically by 
LSMEANS, lowercase in the column and uppercase in the row within the same variable. Values represent a pool of intestinal contents of 3 birds per box, 
totaling an average of 24 birds per treatment. 
 
Treatments 
Bacteria domain   Lactobacillus spp.   Bifidobacterium spp.   Enterococcus spp.   Clostridium cluster XIV 
UD CD   UD CD   UD CD   UD CD   UD CD 
Interaction 
Control 10.59 Aa 10.57 Aa 
 
6.22 Bc  9.03 Aa 
 
4.79 5.32 
 
6.13  6.37  
 
9.94 Ba 10.48 Aa 
Monensin 10.08 Aa 9.71  Bb 
 
8.21 Bb 9.53 Aa 
 
4.96 4.97 
 
6.12  6.21  
 
9.85  Ba 10.17 Aa 
CNSL- Castor oil¹ 10.54 Aa 10.68 Aa 
 
8.88 Aa 8.88 Aa 
 
4.45 4.52 
 
6.07  5.63  
 
9.80 Aa 9.51 Ab 
Challenge 
Challenge 10.4 10.32 
 
7.78 B 9.15 A 
 
4.91 4.76 
 
6.11 6.04 
 
9.81 9.84 
Additives 
Control 10.58 a 
 
7.63 b 
 
5.05 a 
 
6.25 a 
 
10.06 a 
Monensin 9.89 b 
 
8.88 a 
 
4.97 ab 
 
6.12 b 
 
9.91 a 
CNSL- Castor oil 10.38 a 
 
8.89 a 
 
4.49 b 
 
5.86 b 
 
9.66 b 
Probability 
Additive*challenge <0.0001 
 
<0.0001 
 
0.8323 
 
0.0863 
 
0.0085 
Challenge 0.5094 
 
<0.0001 
 
0.3515 
 
0.5452 
 
0.4291 
Additive 0.0166 
 
<0.0001 
 
<0.0127 
 
0.0499 
 
0.0013 
SEM 0.24   0.21   0.138   0.11   0.074 
5
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Table 6. Copy number of Salmonella enterica, Clostridium perfringens, 
Escherichia coli, Staphylococcus aureus in the intestinal content of broiler 14 
days after challenge with coccidiose 
Treatment 
S. enterica  C. perfringens E.coli S.aureus 
UD CD UD CD UD CD UD CD 
Interaction 
Control 4.17 4.18 6.60 Ba 7.14 Aa 6.63 Aa 6.53 Aa 6.97 Ba 7.39 Aa 
Monensin 4.12 4.24 5.28 Bb 6.80 Aa 5.89 Ab 6.00 Ab 6.83 Ba 7.42 Aa 
CNSL- Castor oil² 4.23 4.31 5.18 Ab 5.27 Ab 5.60 Bb 6.66 Aa 6.77 Aa 6.62 Ab 
Challenge 
Challenge 4.18 4.23 5.50 B 6.81 A 6.00 A 6.10 A 7.05 6.95 
Additives 
Control 4.27 6.62 a 6.07 7.18 a 
Monensin 4.18 5.23 b 5.95 7.13 a 
CNSL- Castor oil ² 4.25 5.87 b 6.15 6.70 b 
Probability 
Additive*challenge 0.924 0.0129 0.0308 0.0018 
Challenge 0.6566 0.0115 0.7449 0.3359 
Additive 0.7855 <0.0001 0.8647 0.0009 
SEM 0.145 0.154 0.252 0.0952 
¹ log10 copy number of 16S RNA gene in 1 gram of intestinal contents. UD: unchallenged broilers, 
CD: broilers challenged with coccidiosis. . ² Essential (US Patent N°. 8,377,485; Oligo Basics Ind. 
Ltda., Cascavel, Paraná, Brazil). SEM: Standard Error of the Mean. Means with different letters differ 
statically by LSMEANS, lowercase in the column and uppercase in the row within the same variable. 
Values represent a pool of intestinal contents of 3 birds per box, totaling an average of 24 birds per 
treatment 
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Figure 2. Fold-change of genus 16S rRNA copy number of bacterial group of 
broilers challenged or not with coccidiosis and receiving different additives 
compared to the unchallenged group with no additive. Means ± standard. 
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Abstract  
The aim of this study was to evaluate the effect of a blend commercial of liquid 
cashew nut shell liquid and castor oil (CNSL - Castor oil) on the immune response 
of broilers challenged or not with coccidiosis. A total of 864 one - day - old male 
chicks (Cobb) were randomly distributed in 6 treatments (8 pen / treatment and 18 
chicks / pen) in a 3 x 2 factorial design with 3 additives: control (non- additive), 100 
ppm of Monensin or 0.15% CNSL - Castor oil; and 2 challenge status at 14 days of 
age: unchallenged birds or inoculated by gavage with 1 mL of solution containing 
oocysts sporulated with amount of Eimeria tenella, Eimeria acervulina and Eimeria 
maxima. Although the positive control treatment (non-additive and challenged) and  
CNSL - Castor oil had similar variation in weight gain (ΔBWG = -132% and - 
133%, respectively) compared to unchallenged birds fed without additives, in birds 
fed diets containing CNSL - Castor oil most of the variation presented is due to the 
higher maintenance requirement, not associated with food efficiency. In the 
second week after the challenge, the treatment with CNSL - Castor oil presented a 
ΔBWG less expressive than the other treatments, respectively -52%; -43% and -
15% for the positive control, monensin and CNSL - Castor oil treatments. At 7 and 
14 days post challenge, there was a higher excretion of oocysts in the control 
group, and CNSL - Castor oil and monensin did not differ (P>0.05). The CNSL - 
Castor oil group increased the gene expression of IFN, IL-6 and TNF (P<0.05) and 
the control group increased COX and IL-1 (P>0.05). The heterophils / lymphocyte 
ratio was lower for monensin treatment (P>0.05). The unchallenged birds that 
received monensin presented higher gene expression of IFN, COX and IL-1 
compared to the other treatments (P<0.01), and the CNSL - Castor oil group 
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reduced gene expression, with the exception of TNF. The commercial blend of 
cashew nut liquid and castor oil modulated the inflammatory response against 
Eimeria spp .. In the absence of the parasite, there was no stimulation of the 
genes involved inflammatory response, demonstrating that the blend is an 
effective tool in modulating the imune system.  
 
Keywords:  cashew nut, castor oil, challenge, coccidiosis, interleukins  
 
Implications  
Coccidiosis reduces broiler performance, increases the physiological cost of the 
immune system, both by the presence of the parasite and its effect on intestinal 
health. The blend of functional oils potentiated the host immunity against Eimeria, 
with a reduced weight gain, but reducing the excretion of oocysts  similar to the 
ionophore. Inflammatory response increase was essential for the birds protection, 
with a smaller variation in the weight gain in the two week after challenge. These 
results demonstrate that the functional oil blend use provided a slower recovery of 
the animals, but as effective as those with ionophore. 
 
Introduction  
Coccidiosis usually occurs subclinically in birds, which makes it difficult to 
diagnose the disease in a timely manner to begin treatment before loss of 
performance occurs (Cornelissen et al., 2009). Studies with the major species of 
Eimeria have revealed that innate and cell-mediated immunity have a fundamental 
action against the pathogen, both by the production of cytokines and by the direct 
cytotoxic attack on the affected cells. (Lillehoj e Choi, 1998; Laurent et al., 2001). 
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The major proinflammatory cytokines, such as IL-1, IL-6 and TNF-α, are 
responsible for the acute-phase results that is related to systemic and metabolic 
changes, characterized not only by appetite decrease, but also by increased basal 
metabolic rate, skeletal muscle degradation, and acute-phase hepatic protein 
synthesis (Kogut e Klasing, 2009).  Jiang et al. (2010) using lipopolysaccharide 
(LPS) challenge, concluded that only 59% of the performance loss is due to the 
reduction in feed intake, while 41% is due to other factors, probably associated 
with the immune response. Anticoccidial drugs are given preventively and 
continuously in the diet to minimize problems with coccidiosis. The monensin is an 
ionophore widely used in poultry production, however Eimeria spp. strains 
resistant to ionophores were already identified (Chapman et al., 2010). In addition, 
the constant discussion about reducing the use of antibiotics as growth promoters 
has stimulated the search for alternative methods that can reduce the impact of 
this parasite and act as growth promoters at the same time. 
Phytogenic may act as antimicrobial and anti-inflammatory agents with similar 
effects of some drugs used in animal production, because, in the general, they are 
composed of a complex blend of volatile substances such as terpene 
hydrocarbons, simple alcohols, aldehydes, among others that are 
pharmacologically active (Applegate et al., 2010). Within the category of 
phylogenetic, the functional oils are defined as those that have an action beyond 
the nutritional value (Murakami et al., 2014). One such product is a blend of 
cashew nut liquid and castor oil. Evaluating this blend in the diet of broilers 
challenged with coccidiosis, Murakami et al. (2014) observed weight gain increase 
and feed conversion improvement, as well as the gain of 100 kcal of metabolizable 
energy in the diet when compared to the control treatment (Bess et al., 2012; 
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Murakami et al., 2014). According to Bess et al. (2012), this increase in energy 
availability may be associated to antimicrobial and anti-inflammatory effects of 
functional oils. However, there is no literature demonstrating the anti-inflammatory 
action of this product in vivo. 
Thus, the aim of this study was to evaluate the effect of commercial blend of 
cashew shell liquid and castor oil on the immune response of broilers challenged 
or not with coccidiosis. 
 
Material and methods  
The Institutional Animal Care and Use Committee at Federal University of Rio 
Grande do Sul reviewed and approved the protocol used in the present study 
(register number 29814). 
 
 Animals, diets and experimental design 
A total of 864 one-day-old male chicks (Cobb 500) were obtained in a commercial 
hatchery and housed in two identical experimental rooms, composed of 48 pens (8 
pens / treatment and 18 birds / pens). The nutritional program consisted of three 
diets: pre-initial (1 to 7 days), initial (8 to 21 days) and growth (22 to 28 days) 
based on the levels of nutritional requirements recommended by the Brazilian 
Tables of Poultry and Swine (Rostagno et al., 2011). The nutritional composition 
was the same for all treatments, varying only the additive used in the diet. 
Metabolizable energy and crude protein were, respectively, in the three phases 
3000 kcal / kg and 22.2%; 3050 kcal / kg and 21%; 3150 kcal / kg and 19.69%. 
The experimental design was completely randomized in a 3x2 factorial design with 
3 additives: control (non- additive), 100 ppm of Monensin or 0.15% CNSL- Castor 
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oil; challenged or not with coccidiosis. Both additives, CNSL- Castor oiland sodium 
monensin, were introduced by replacing the inert (kaolin) in the basal diet. The 
treatment unchallenged without additives was denominated negative control and 
the challenged treatment was positive control. 
 
Health challenge 
At 14 days of age, 1mL of sporulated oocysts of E. tenella (10x10³), E. acervulina 
(200x10³) and E. maxima (80x10³) were inoculated by gavage. The oocysts were 
obtained from the Laboratório de Biologia Molecular de Coccídias (University of 
São Paulo, Brazil). Unchallenged chickens received 1 mL of saline. 
 
Sampling and data collection 
Weight gain and feed intake were measured at 7 and 14 days after the health 
challenge, respectively, 21 and 28 days of age. At 21 days of age (7 days after the 
challenge), three birds per replicate were euthanized by cervical dislocation and 1 
cm of the duodenum (in the final portion), the jejunum (before the Meckel's 
diverticulum) and the cecal tonsils were aseptically collected. The samples were 
washed in cold PBS (phosphate buffered saline), minced, immediately frozen in 
liquid nitrogen and stored at -80° C until analysis of gene expression. 
From these three birds, one was randomly chosen to collect 5 cm of fragment of 
duodenum (final portion), jejunum (before Meckel's diverticulum) and ileum (before 
cecum entry) to evaluate intestinal health. In the period before euthanasia, blood 
from the ulnar vein was collected to perform leucogram of one bird per repetition. 
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Oocysts count 
After 7 and 14 days of challenge the litter as collected in five different points, 
forming a pool of samples per pen. The number of oocysts was determined as 
described by Costa and Paiva (2009), using a McMaster chamber and according 
to the formula: total oocysts / pen = (oocysts counted × dilution factor × [sample 
volume / counting chamber volume) / 2.  
 
Intestinal health index  (ISI) 
The ISI – ““I See Inside” (INPIBR1020150036019) is an intestinal health index  
generated from the histological changes that are submitted to the following formula 
ISI = Σ (EL * FI). Where: Σ sum, EL is the lesion score (0-3 being 3 the most 
severe) attributed to the observed histological changes, and FI is the pre-
established Impact Factor (ranges from 1-3 being 3 the most severe) that is 
attributed to the change according to how much it affects the evaluated organ 
function. Details of the method are presented in Table 1 (Kraieski et al., 2017). 
The fragments collected in the experiment were fixed in buffered 10% formalin 
solution, later prepared in paraffin blocks and stained with hematoxylin and eosin 
with Alcian Blue. For the evaluation of intestine was carried out the reading in 10x 
objective in 5 villi per bird selected from the count performed on the 4X objective. 
Leica DM1000 LED Optical Microscope was used for microscopic analysis. 
 
Gene expression 
Total RNA was extracted from the pool of samples obtained separately in the 
duodenum, jejunum and cecal tonsils of 3 birds per pen using the protocol of the 
Invitrap® Spin Tissue RNA kit (Stratec). An aliquot of 20-20 mg of each sample 
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was used. The RNA was eluted by washing the column membrane twice with 25 μl 
of RNase-free water. The total concentration of RNA was determined by Qubit 
(Qubit 3.0 Fluorometer) and RNA purity by optical density (OD) (NanoDrop-1000, 
Thermo Fisher Scientific, Waltham, MA) checking the ratio of OD 260/280. 
Reverse transcription was performed using the high throughput cDNA transcription 
kit of QuantiTec Kit (Qiagen), following the manufacturer's protocol and the cDNA 
was stored at -20 ° C. A Step One Plus (Applied Biosystems) was used for 
quantitative PCR (rt-qPCR). 
The cDNA was diluted 1: 100 in nuclease-free water and 10 μL were added to 
each well of the plate. Subsequently, 10 μL of a mix containing 2.0 μL of 10x PCR 
buffer was added; 1.6 μl of MgCl2 [50 mM] 0.5 μl of each primer [10 μM]; 0.2 μl 
dNTP [5 mM]; 2.0 μL Syber green [1x], 0.05 μL Platinum® Taq DNA Polymerase 
[5U / μL] 5 μL of DNA, and the remainder of ultra pure water to complete the 
volume. The conditions for qPCR were 94 °C for 5min, 35 cycles at 94 °C for 30 s, 
annealing temperature specific for each oligonucleotide pair (Table 2) for 30s and 
72 °C for 30 s. The specificity of the PCR products was checked at the end of the 
reaction by analysing the dissociation curve. In addition, the size of the amplicons 
was verified by electrophoresis. The values obtained for each gene were 
normalized and the gene expression was calculated  in relation to the negative 
control group (without challenge and without additive), as described by Livak e 
Schmittgen (2001). 
 
Calculations and statistical analysis 
The Pearson correlation coefficient was determined as a measure of the linear 
correlation between the weight gain variation (ΔBWG) and the feed consumption 
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variation (ΔFI) between the negative control and the indicated treatment. The 
relationship between ΔFI and ΔBWG for the birds challenged the negative control, 
receiving monensin or CNSL- Castor oil, exposure was analyzed using linear 
regression: ΔBWG = α + β x ΔFI as described by Pastrorelli et al. (2012). The 
analysis was carried out using the REG procedure in SAS. The intercept (α) 
represents reduction in BWG related to changes in maintenance (i.e., not 
associated with changes in FI). The slope (β) represents the extent of BWG 
change associated with the reduction in feed efficiency in challenged birds. 
The factorial was analysed by ANOVA and included the effects of the additives, 
challenge and their interactions for all the studied variables. The LSmeans 
compared the means when significant differences were found. The GLM 
procedure of the SAS statistical package, version 9.2 (SAS Institute 2002) was 
used. 
 
 
Results  
Growth Performance  
The ΔBWG showed a linear fit to the ΔFI in the first and second weeks evaluated 
(Fig 1 and 2). The ΔBWG was lower for all treatments in the second week, 
demonstrating that the greatest impact resulting from coccidiosis occurred in the 
first week after infection. In addition, the intercepts of all equations were negative 
in both weeks, suggesting that changes in maintenance requirements contributed 
to a negative ΔBWG even when feed intake was not affected. 
 Most of the ΔBWG observed in the challenged groups in relation to the control 
birds was due to worsening of feed efficiency, except for the group that received 
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CNSL- Castor oil in the first week. The maintenance-related fraction was twice 
large (2-fold) in CNSL- Castor oil group than in the positive control, and 24 times 
(24-fold) higher than Monensin treatmet, which had the lowest ΔBWG. Groups fed 
diets containing CNSL- Castor oil presented lower ΔBWG, both due to 
maintenance (4%) and feed efficiency (11%) in the second week. 
 
Oocysts count 
The total oocysts count for birds fed diets with monensin or CNSL- Castor oil was 
reduced when compared to the positive control (P<0.05) (Fig. 3). As expected, in 
unchallenged chickens no oocysts were detected into excreta. 
 
Blood analysis and ISI score 
The percentage of heterophiles and the heterophiles / lymphocyte ratio presented 
interaction (P<0.05).The non-challenged birds had no difference between the 
treatments (P> 0.05), but the group challenged of the positive control and the 
CNSL- Castor oil had a higher percentage of heterophiles and a higher 
heterophiles / lymphocyte ratio than those of Monensin (Fig.4). In addition, birds 
receiving Monensin showed similar between non-challenged and challenged. The 
number of total leukocytes and the percentage of eosinophils did not present a 
difference between the treatments, and the percentage of lymphocytes and 
monocytes differed only for the challenge factor (P<0.05), in which unchallenged 
birds had a higher percentage of lymphocytes and lower monocytes when 
compared to challenged birds (data not shown). 
Figure 5 shows the average of the maximum scores obtained by the  ISI 
morphometric index, described by Kraieski et al. (2016). There was no interaction 
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between the factors, therefore, regardless of the challenge, CNSL- Castor oil 
presented higher ISI in all evaluated segments, and monensin and control did not 
differ. The detailed ISI results are presented in annex 1. 
 
Gene expression 
The mRNA expression of the genes evaluated in the duodenum and jejunum at 7 
days after the challenge (21 days of age) is shown in Figure 6. In these two 
segments, there was interaction between the additives and challenge for all genes 
evaluated. Contrary to the cecal tonsils where there was no interaction between 
the factors, however, all the genes evaluated presented higher expression for the 
challenged birds (P<0.05). In this segment, there was an effect of the additive only 
for Inos expression, which presented higher expression in the control group, 
followed by monensin and CNSL- Castor oil (P<0.05). (Data not shown) 
The challenged birds that received CNSL- Castor oil presented lower Inos gene 
expression and higher NF-kB and IL-6 than monensin in the duodenum and 
jejunum (P<0.05). There was upregulated expression of IFN and TNF in relation to 
the positive control and monensin in the jejunum (P<0.05). In both segments of the 
birds of the positive control, there was a upregulated expression of IL-1 and in the 
jejunum greater COX expression in relation to the monensin and CNSL- Castor oil 
birds; between these treatments, there were no differences for both genes 
(P>0.05). The non-CNSL- Castor oil-challenged birds presented lower gene 
expression in relation to the other treatments in at least one of the segments 
(P<0.05), except for the TNF gene, which showed no difference among treatments 
in the jejunum (P>0.05) and was lower for the positive control treatment in the 
duodenum (P<0.05). The treatment with monensin presented higher gene 
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expression of IFN, COX and IL-1 than the other treatments in both segments (P 
<0.01). 
 
Discussion  
The CNSL- Castor oil additive stimulated the inflammatory response of birds by 
increasing the immune response against the parasite in the week after the 
challenge. This is seen in the increase of some proinflammatory interleukins (IFN, 
TNF and IL-6), the heterophiles / lymphocyte ratio in the blood, the ISI and the 
higher maintenance expenditure. However, birds excreted a quantity of oocysts 
similar to birds with monensin. The opposite occurred with the positive control, 
which presented lower inflammatory response and greater oocysts excretion, 
demonstrating that the parasite continues to proliferate. 
Regardless of the additives used, as expected, the challenged birds presented 
worse ISI, higher heterophiles / lymphocyte ratio and higher expression of Inos, 
TNF, IFN, NF-kB, Cox, IL-1 and IL-6 in the week following the challenge in all 
analyzed intestinal segments, characterizing an ongoing inflammatory process 
against the pathogen (Laurent et al., 2001; Cox et al., 2010; Zhou et al., 2014; 
Chen et al., 2016; Zhang et al., 2016). According to Kogut e Klasing (2009) and 
Klasing (2004), the acute phase of the immune response is the first defence 
mechanism and is related to systemic and metabolic alterations. 
The immune response against the parasite is complex and there are mechanisms 
that are not clear yet. It is known that the innate immune system and cell mediated 
has a fundamental action in response to the pathogen. The immune system does 
not prevent sporozoite invasion into enterocytes, but avoids their development  
(Allen e Fetterer, 2002). Innate immunity recognizes the pathogen through toll-like 
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receptors (TLRs) that use the MyD88 adapter protein to activate the genes of four 
major pro-inflammatory proteins IL-1, IL-6, IL-12, TNF-α and IFN-γ (Tizard 2009). 
These cytokines play important regulatory roles modulating the course of the 
immune response during infection (Allen & Fetterer, 2002). It was observed that 
the reaction developed in the treatment that received CNSL- Castor oil modulates 
the immune system to increase gene expression of TNF-α, IL-6 and IFN-y and 
reduce IL-1 expression and COX-2, contrary to the control Positive that increased 
Cox-2 and IL-1, being the first one more effective than the second, which can be 
observed by the reduction of oocysts. 
The efficacy of CNSL- Castor oil treatment in reducing oocysts can be explained 
by the increase in IFN-γ. Because IFN-γ expression stimulates cell-mediated 
immunity (Th1) that is crucial in the immune response against Eimeria (Lillehoj e 
Choi, 1998). IFN-γ produced mainly by CD4 + cells can directly inhibit sporozoite 
development by increasing the cytotoxic activity of CD8 + cells and activating 
macrophages (Allen e Fetterer, 2002). Lee et al. (2008) observed that the use of a 
phytogenic composed of Prunus salicin in the feed increased the expression of 
IFN-γ, promoting the protective immunity against coccidiosis, with reduction in 
oocyst excretion and weight loss 10 days after infection, in agreement with the 
results obtained in this study. 
The TNF-α and interleukin IL-6 are inflammatory markers stimulated by 
macrophages and NF-kB (Kim et al., 2008), and in the present study, the 
heterophiles  / lymphocyte ratio increased in the blood, reflecting the ISI 
worsening. According to Kraieski et al., (2016, the increase in ISI is related to the 
increased infiltration of lymphocytes in the lamina propria, with epithelial thickness, 
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goblet cells, congestion and enterocytes proliferation or infiltration of inflammatory 
cells. 
When applying the Pastorelli et al. (2012) aproach to evaluate the link between 
feed intake and weight gain, although the positive control treatment and CNSL- 
Castor oil presented a similar ΔBWG (-132%), the partition of this variation was 
different. While the positive control presented a more significant change due to the 
fraction associated with the change in feed efficiency, that may be associated with 
a reduction in feed consumption (-86%), the variation in the CNSL- Castor oil 
group was due to changes associated with maintenance, not associated with ΔFI 
(-94%). Zhang et al. (2016) observed that ΔBWG in broilers after coccidiosis 
challenge was attributed to change in maintenance. The nutrients requirements for 
maintenance are higher during the challenge with coccidiosis, particularly, in the 
first week after challenge (Laurent et al., 2001; Cornelissen et al., 2009; Cox et al., 
2010). The increased requirement probably includes metabolic costs for repairing 
damaged tissues, immune system stimuli, and reduced ability of animals to utilize 
nutrients (Chen et al., 2016; Grenier et al., 2016). The innate immune system may 
causes considerable collateral damage, such as fever and inflammatory reactions 
that consume resources, reducing nutrient reserves and increasing catabolism 
(Klasing e Iseri, 2013; Iseri e Klasing, 2014). These consequences make 
inflammation a highly undesirable phenomenon in animal production. One week 
after the challenge, the greater inflammatory response in CNSL- Castor oil 
treatment was important to transform the immune system in a more effective 
mechanism, not only against coccidia, but also against pathogenic bacteria, 
preventing intestinal dysbiosis. 
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This fact was proven the following week, in which CNSL- Castor oil reduced the 
population of C. perfringens and S. aureu, considered opportunistic bacteria 
(Moraes et al. / Article in process). In this sense, it is possible to say that the mode 
of action of CNSL- Castor oil is similar to a vaccine, potentiating the host immune 
system against the pathogens and acting as a modulator at the same time. The 
monensin group presented a lower inflammatory process, characterized by the 
downregulate of TNF, IFN, NF-kB, Cox, IL-1 and IL-6 in at least one of the 
evaluated segments, greater anticoccidial activity acts on the parasite when it is 
outside the host cell and can kill the coccidia on the third day after the challenge, 
in the form of merozoites, before the inflammatory process peak, which occurs at 
the end of the first week (Laurent et al., 2001; Chapman et al., 2010; Cox et al., 
2010). 
This modulation was also observed in unchallenged birds, which presented lower 
gene expression of most of the interleukins evaluated when supplemented with 
CNSL- Castor oil, unlike the monensin treatment that increased IFN-γ, COX -2 and 
IL-1. This may be a better microbiota balance reflection, confirmed by the analysis 
of the microbiota at 28 days of age, when a larger population of Lactobacillus spp 
was observed for the CNSL- Castor oil group (Moraes et al. / Article in process). 
These bacteria have the ability to modulate the gene expression of cytokines, toll-
like receptors and T cells (Brisbin et al., 2011). 
The commercial blend of cashew nut liquid and castor oil modulated the 
inflammatory response against Eimeria spp .. In the absence of the parasite, there 
was no stimulation of the genes involved inflammatory response, demonstrating 
that the blend is an effective tool in modulating the imune system.  
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Table 1. Intestinal helth index classification table 
 
¹ Maximum score represents the results considering an observation of score 3 for 
each alteration, multiplied by the impact factor (fixed value for each alteration) and 
summed at the final. (adapted from Kraiski et al., 2016) 
Alteration Impact Factor  
Self-blade thickness 2 
Epithelial thickness 1 
Proliferation of enterocytes 1 
Epithelial plasma infiltration 1 
Mixed inflammatory infiltration of lamina propria 3 
Goblets cells 2 
Congestion 2 
Necrosis (apical karyolysis) 3 
Presence of oocysts 3 
Maximum score ¹ 54 
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Table 2. Target gene and primers used for the analysis of gene expression 
Target Sequence ID Reference 
*B- actin_F 5' ACCTGAGCGCAAGTACTCTGTCT 3' 
 NM205518.1 Xie et al. (2014) *B- actin_R 5' CATCGTACTCCTGCTTGCTGAT 3' 
    *GAPDH_F¹ 5' CCTAGGATACACAGAGGACCAGGTT 3' 
NM_204305 Tan et al. (2014) *GAPDH_R 5' GGTGGAGGAATGGCTGTCA 3' 
    IL-1B_ F 5' ACT GGG CAT CAA GGG CTA 3' 
NM_204524 Tan et al. (2014) IL-1B_R 5' GGT AGA AGA TGA AGC GGG TC 3' 
    IL-6_ F 5' TTTATGGAGAAGACCGTGAGG 3' 
NM_204628 Long et al.(2011)  IL-6_R 5' TGTGGCAGATTGGTAACAGAG 3' 
    TNF-α_F 5' TGCTGTTCTATGACCGCC 3' 
AY765397 Hu et al. (2015) TNF-α_R 5' CTTTCAGAGCATCAACGCA 3' 
    IFN-y_F 5' AGCTGACGGTGGACCTATTATT 3' 
 Y07922 Lee et al. (2012) IFN-y_R 5' GGCTTTGCGCTGGATTC 3' 
    Cox-2_F 5' GGTGAGACTCTGGAGAGGCAAC 3' 
M64990 Laurent et al. (2001) Cox-2_R 5' GTTGAACAGAAGCTCAGGGTCA 3' 
    iNOS_F² 5' CCTGTACTGAAGGTGGCTATTGG 3' 
D85422  Cox et al. (2010) iNOS_R 5 AGGCCTGTGAGAGTGTGCAA 3' 
    NF-kB_F³ 5' GTGTGAAGAAACGGGAACTG 3' 
NM_205129 Tan et al. (2014) NF-kB_R 5' GGCACGGTTGTCATAGATGG 3' 
F: forward; R reverse; ID: GenBank access number ; *Housekeeping genes 
¹ Glyceraldehyde-3-phosphate dehydrogenase 
² Inducible nitric oxide synthase 
³ Nuclear factor kappa B 
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Figure 1. (a) . Relationship between the change in BW gain (ΔBWG) and 
feed intake (ΔFI) of broiler chicks at 14–21 d of age challenged with Eimeria 
spp. supplemented with inert (C) CNSL - Castor oil (Essential (US Patent N°. 
8,377,485; Oligo Basics Ind. Ltda., Cascavel, Paraná, Brazil) (E) monensin 
(M) in the diet. Responses are expressed as results of the challenged birds 
relative to negative control. (b) Partitioning of the reduction in average BW 
gain between the fraction due to the change in maintenance ( , not 
associated with ΔFI) or change in feed intake ( , associated with ΔFI). ΔFI, 
Change in feed intake. 
 
       Control                  Monensin           CNSL -Castor oil 
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Figure 2. Relationship between the change in BW gain (ΔBWG) and feed 
intake (ΔFI) of broiler chicks at 21–28 d of age challenged with Eimeria 
spp. supplemented with inert (C) CNSL- Castor oil (Essential (US Patent 
N°. 8,377,485; Oligo Basics Ind. Ltda., Cascavel, Paraná, Brazil) (E) 
monensin (M) in the diet. Responses are expressed as results of the 
challenged birds relative to negative control. (b) Partitioning of the 
reduction in average BW gain between the fraction due to the change in 
maintenance ( , not associated with ΔFI) or change in feed intake ( , 
associated with ΔFI). ΔFI, Change in feed intake. 
       Control                  Monensin           CNSL-Castor oil 
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Figure 3. Excretion of oocysts in chickens challenged with coccidiosis at 7 and 
14 days post infection. ¹ Essential (US Patent N°. 8,377,485; Oligo Basics Ind. 
Ltda., Cascavel, Paraná, Brazil Averages with different lowercase letters differ 
statically by LSMEANS in the week evaluated. Values represent the box, 
totaling 8 boxes per treatment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
       Control             CNSL - Castor oil ¹           Monensin 
  
78 
 
 
 
 
 
 
 
 
 
 
 
 
b 
Figure  4. Percent of Heterophils (a) and Heterophiles / Lymphocyte ratio (b) in 
challenged broilers (CH) or non (NC) with coccidiosis.¹ Essential (US Patent N°. 
8,377,485; Oligo Basics Ind. Ltda., Cascavel, Paraná, Brazil. Means with different 
letters differ statically by LSMEANS, lowercase for additive and uppercase for 
challenged. Values represent 1 birds by box, totaling an average of 8 birds per 
treatment 
Figure 5. Intestinal Health Index (ISI) of broilers challenged or not at 21 
days of age receiving different additives.¹ Essential (US Patent N°. 
8,377,485; Oligo Basics Ind. Ltda., Cascavel, Paraná, Brazil. Averages 
with different lowercase letters differ statically by LSMEANS in the week 
evaluated. Values represent the 1 bird by box, totaling 8 boxes per 
treatment 
 
a 
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Figure 6. Interaction between coccidiosis challenge and different additives in 
the gene expression of interleukins in the duodenum and jejunum. Gene 
expression was calculated in relation to treatment that did not receive 
challenge or additive.¹ Essential (US Patent N°. 8,377,485; Oligo Basics Ind. 
Ltda., Cascavel, Paraná, Brazil. Capitalized averages differ statistically for 
the challenge, with lowercase letters differing for the additive within the 
challenge by LSMEANS using the data transformed into Log10 
 ontrol 
 onensin 
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Annex  
 
 
Anexx 1 - ISI histological analysis scores mean and standard error different treatments in samples of duodenum of broilers 
with 21 days of age 
Treatmens 
Self-blade 
thickness 
Epithelial 
thickness 
Proliferation 
of 
enterocytes 
Epithelial 
plasma 
infiltration 
Mixed 
inflammatory 
infiltration of 
lamina 
propria 
Goblets cells Congestion 
Necrosis 
(apical 
karyolysis) 
Presence of 
oocysts 
Score 
Challenge 
 1,76±0,14 b  2,67±0,10 b 2,47±0,10 b 0,77±0,03 a 1,63±0,18 1,91±0,15 0,90±0,12 b 0,05±0,03 0,13±0,06 12,33±0,46 b 
 3,65±0,15 a 3,22±0,09 a 3,11±0,10 a 0,61±0,04 b 1,55±0,17 1,75±0,16 1,46±0,17 a 0,05±0,039 3,20±0,33 18,62±0,57 a 
Additives 
Control 2,37±0,19 b 2,76±0,12 b 2,51±0,13 b 0,61±0,04 1,29±0,20 1,37±0,18 1,00±0,17 0,08±0,05 2,53±0,40 14,55±0,70 b 
Monensin 2,37±0,19 b 2,81±0,13 b 2,65±0,13 b 0,75±0,04 1,83±0,22 1,52±0,19 0,97±0,17 0±0 1,20±0,25 14,12±0,69 b 
CNSL - CO ¹ 3,37±0,20 a 3,26±0,11 a 3,21±0,11 a 0,70±0,05 1,66±0,22 2,60±0,191 1,57±0,20 0,08±0,05 1,26±0,28 17,75±0,64 a 
Interaction 
Control_Un 1,60±0,23 2,56±0,17 2,23±0,17 0,68±0,06 1,08±0,26 2,10±0,29 ab 0,70±0,20 0,08±0,083 0,00±0,00 c 11,05±0,66 
Monensin_Un 1,50±0,24 2,53±0,19 2,30±0,17 0,80±0,057 0,58±0,07 1,20±0,24 bc 0,90±0,21 0±0 0,00±0,00 c 11,48±0,81 
Control _CH 3,15±0,28 2,96±0,18 2,80±0,18 0,55±0,073 1,50±0,29 0,65±0,18 c 1,30±0,27 0,083±0,08 5,06±0,66 a 18,06±1,08 
Monensin_CH 3,25±0,26 3,10±0,16 3,00±0,18 0,70±0,064 1,41±0,29 1,85±0,28 ab 1,05±0,28 0±0 2,40±0,45 b 16,76±1,02 
CNSL - CO _UN 2,20±0,28 2,93±0,16 2,90±0,16 0,83±0,072 1,58±0,32 2,45±0,24 a 1,10±0,21 0,08±0,08 0,40±0,20 c 14,48±0,85 
CNSL - CO _CH 4,55±0,20 3,60±0,14 3,53±0,14 0,58±0,07 1,75±0,31 2,75±0,29 a 2,05±0,33 0,08±0,08 2,13±0,50 b 21,03±0,77 
Probability 
Challenge 0,000 0,000 0,000 0,004 0,740 0,437 0,080 1,000 0,000 0,000 
Additives 0,000 0,006 0,000 0,132 0,198 0,000 0,340 0,368 0,000 0,000 
Additive*Challenge 0,257 0,735 0,927 0,507 0,101 0,001 0,303 1,000 0,000 0,598 
¹ CNSL- Castor oil_ Essential (US Patent N°. 8,377,485; Oligo Basics Ind. Ltda., Cascavel, Paraná, Brazil. 
a,b,c,d 
Different letters in the same column 
indicate a significant difference of P ≤ 0.0.5 by Tukey's test. 
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Anexx 2 - ISI histological analysis scores mean and standard error different treatments in samples of jejunum of broilers with 
21 days of age 
Treatmens 
Self-blade 
thickness 
Epithelial 
thickness 
Proliferation 
of 
enterocytes 
Epithelial 
plasma 
infiltration 
Mixed 
inflammatory 
infiltration of 
lamina propria 
Goblets 
cells 
Congestion 
Necrosis 
(apical 
karyolysis) 
Presence of 
oocysts 
Score 
Challenge 
Unchallenged 1,83±0,13 b 2,50±0,07 a 1,03±0,08 b 0,38±0,03 b 3,75±0,18 3,78±0,11 a 1,31±0,13 1,47±0,19 b 0,04±0,03 16,11±0,60 b 
Challenge 3,13±0,13 a 2,16±0,08 b 1,55±0,10 a 0,61±0,03 a 4,86±0,15 3,13±0,12 b 1,15±0,13 3,41±0,25 a 3,02±0,23 23,05±0,68 a 
Additives 
Control 2,65±0,17 a 2,21±0,10 1,48±0,12 a 0,37±0,04 b 4,16±0,20 3,37±0,16 1,05±0,14 2,12±0,27 b 1,33±0,20 18,77±0,75 b 
Monensin 2,025±0,17 b 2,26±0,08 0,98±0,10 b 0,55±0,04 a 4,25±0,21 3,47±0,13 1,07±0,16 1,20±0,21 c 0,90±0,17 16,74±0,73 b 
CNSL - CO¹ 2,77±0,15 a 2,51±0,09 1,41±0,12 a 0,55±0,04 a 4,50±0,23 3,52±0,13 1,57±0,18 4,00±0,31 a 2,36±0,31 23,23±0,94 a 
Interaction 
Control_Un 2,05±0,21 2,40±0,10 1,30±0,14 0,26±0,05 4,00±0,28 bc 3,75±0,19 1,15±0,22 bc 1,08±0,26 0,00±0,00 c 16,00±0,80 
Monensin_Un 1,30±0,20 2,46±0,11 0,83±0,13 0,43±0,06 3,25±0,31 c 3,65±0,17 0,50±0,16 c 0,66±0,22 0,06±0,06 c 13,16±0,81 
Control _CH 3,25±0,25 2,03±0,17 1,66±0,21 0,48±0,06 4,33±0,30 abc  3,00±0,26 0,95±0,19 bc 3,16±0,44 2,66±0,33 b 21,55±1,17 
Monensin_CH 2,75±0,25 2,06±0,12 1,13±0,14 0,68±0,06 5,25±0,21 a 3,30±0,21 1,65±0,26 ab 1,75±0,35 1,73±0,30 b 20,31±1,03 
CNSL - CO _UN 2,15±0,23 2,63±0,15 0,96±0,18 0,45±0,06 4,00±0,35 bc 3,95±0,21 2,30±0,25 a 2,66±0,41 0,06±0,06c 19,18±1,30 
CNSL - CO _CH 3,40±0,16 2,40±0,11 1,86±0,14 0,66±0,06 5,00±0,29 ab 3,10±0,14 0,85±0,22 bc 5,33±0,40 4,66±0,47 a 27,28±1,14 
Probabiliy 
Challenge 0,000 0,002 0,000 0,000 0,000 0,000 0,360 0,000 0,000 0,000 
Additives 0,002 0,055 0,004 0,005 0,505 0,759 0,030 0,000 0,000 0,000 
Additive*Challenge 0,84 0,803 0,134 0,956 0,019 0,438 0,000 0,088 0,000 0,481 
Additive*Challenge 0,257 0,735 0,927 0,507 0,101 0,001 0,303 1,000 0,000 0,598 
¹ CNSL- Castor oil_ Essential (US Patent N°. 8,377,485; Oligo Basics Ind. Ltda., Cascavel, Paraná, Brazil. 
a,b,c,d 
Different letters in the same column 
indicate a significant difference of P ≤ 0.0.5 by Tukey's test 
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Anexx 3 - ISI histological analysis scores mean and standard error different treatments in samples of ileum of broilers with 21 
days of age 
 
Treatmens 
Self-blade 
thickness 
Epithelial 
thickness 
Proliferation 
of 
enterocytes 
Epithelial 
plasma 
infiltration 
Mixed 
inflammatory 
infiltration of 
lamina 
propria 
Goblets 
cells 
Congestion 
Necrosis 
(apical 
karyolysis) 
Presence of 
oocysts 
Score 
Challenge 
Unchallenged 4,73±0,18 3,35±0,12 b 2,72±0,14 0,50±0,04 b 3,33±0,26 5,15±0,19 2,11±0,20 2,63±0,23 0,00±0,00 24,55±0,79 
Challenge 5,48±0,17 3,92±0,11 a 3,44±0,12 0,91±0,05 a 5,75±0,30 4,98±0,20 1,90±0,17 4,05±0,28 0,95±0,13 31,40±0,84 
Additives 
Control 4,75±0,22 3,43±0,14 b 2,83±0,16 0,54±0,05 b 4,58±0,36 4,30±0,21 b 1,85±0,21 2,95±0,32  0,66±0,13 25,99±1,09 
Monensin 4,65±0,22 3,46±0,14 b 2,98±0,15 0,58±0,05 b 3,91±0,33 5,42±0,21 a 2,20±0,26 3,00±0,29 0,00±0,00 26,22±0,87 
CNSL - CO ¹ 5,90±0,21 4,01±0,15 a 3,38±0,17 1,00±0,07 a 5,12±0,39 5,47±0,27 a 1,97±0,22 4,08±0,34 0,76±0,15 31,72±1,10 
Interaction 
Control_Un 3,90±0,31 d 2,96±0,19 2,16±0,22 b 0,43±0,07 2,50±0,42 b 4,55±0,33 1,85±0,31 1,91±0,37 c 0,00±0,00 b 20,28±1,25 d 
Monensin_Un 4,90±0,30 bcd 3,23±0,21 2,86±0,23 ab 0,36±0,06 3,58±0,44 b 5,05±0,24 2,35±0,39 3,00±0,41bc 0,0±0,00 b 25,35±1,32 cd 
Control _CH 5,65±0,28 ab 3,90±0,18 3,60±0,20 a 0,65±0,07 6,66±0,47 a 4,05±0,28 1,85±0,28 4,00±0,48ab 1,33±0,24 a 31,70±1,45 ab 
Monensin_CH 4,40±0,33 cd d 3,70±0,17 3,10±0,19 a 0,80±0,07 4,25±0,48 b 5,80±0,34 2,05±0,34 3,00±0,43bc 0,00±0,00 b 27,10±1,139 bc 
CNSL - CO _UN 5,40±0,32 abc 3,86±0,22 3,13±0,26 a 0,71±0,08 3,91±0,47 b 5,85±0,39 2,15±0,34 3,00±0,43bc 0,00±0,00 b 28,03±1,38 bc 
CNSL - CO _CH 6,40±0,26 a 4,16±0,20 3,63±0,22 a 1,28±0,10 6,33±0,59 a 5,10±0,38 1,80±0,29 5,16±0,50 a 1,53±0,28 a 35,41±1,58 a 
Probabiliy 
Challenge 0,003 0,001 0,000 0,000 0,000 0,544 0,425 0,000 0,000 0,000 
Additives 0,000 0,006 0,066 0,000 0,046 0,001 0,566 0,017 0,000 0,000 
Additive*Challenge 0,001 0,270 0,022 0,096 0,002 0,059 0,850 0,023 0,000 0,002 
¹ CNSL- Castor oil _Essential (US Patent N°. 8,377,485; Oligo Basics Ind. Ltda., Cascavel, Paraná, Brazil. a,b,c,d Different letters in the same column 
indicate a significant difference of P ≤ 0.0.5 by Tukey's test 
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CONSIDERAÇÕES FINAIS 
 
 
A mistura comercial do líquido da casca de castanha de caju e do 
óleo de mamona possui potencial para ser utilizada como um promotor de 
crescimento apresentando resultado de desempenho semelhante ao ionóforo 
monensina. Trabalhos anteriores relataram que o Essential melhora o 
desempenho animal possivelmente por apresentar atividade anti-inflamatória e 
antimicrobiana. No entanto, contrariando as expectativas, o Essential estimulou 
a resposta imune inata e celular, potencializando o sistema imune do 
hospedeiro contra o parasita e consequentemente aumentou as exigências de 
mantença, desviando recursos e reduzindo o desempenho animal na primeira 
semana após o desafio. Ao mesmo tempo foi efetivo contra o patógeno sendo 
demonstrado pela menor excreção de oocistos.  
Foi possível observar uma redução na população de C.perfringens 
com a utilização do Essential. Essa redução pode ter ocorrido por dois motivos, 
primeiro porque o produto apresenta atividade antibacteriana direto, segundo 
porque pode ter estimulado o sistema imune tornando-o mais responsivo. 
Neste ponto, há uma limitação da pesquisa descrita, pois o sistema imune e a 
microbiota foram avaliados em semanas distintas e uma única vez, permitindo 
apenas fazer especulações baseadas na literatura sobre a sua interação. O 
ideal teria sido realizar ambas as análises aos 7, 14 e 21 dias após o desafio, 
observando respectivamente, o pico da inflamação e o seu efeito na microbiota, 
a fase intermediária quando a microbiota ainda não se reestabeleceu e após, 
quando o sistema, provavelmente, já tenha recuperado a homeostase.  
Esses resultados permitem questionar se realmente o processo de 
inflamação deva ser considerado um fenômeno altamente indesejável do ponto 
de vista da produção, já que no presente caso, a recuperação dos animais foi 
mais lenta, porém ocorreu na mesma grandeza que nos animais que utilizaram 
o ionóforo. Principalmente com a possibildade da proibição dos antibióticos 
promotores de crescimento, é preciso ampliar o conhecimento da saúde 
intestinal e focar em um sistema imune que esteja pronto para atuar quando for 
necessário. Possivelmente, no futuro, vamos formular rações e tomar decisões 
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com base em biomarcadores moleculares de saúde intestinal, que podem ser a 
comunidade microbiana, as interleucinas ou ainda biomarcadores ainda não  
descobertos. 
A realização desta pesquisa, entre outras realizadas durante o 
doutorado, proporcionou uma experiência na organização de materiais e 
principalmente de atividades que envolviam um grupo de pessoas para a 
execução de tarefas que exigiram uma alta carga de trabalho manual Também 
possibilitoua convivência em diferentes laboratórios com outros focos que não 
a produção animal, contribuindo para um aprendizado interdisciplinar e uma 
visão sistêmica do objeto de pesquisa. Além disso, essa rede possibilitou a  
discussão  de  metodologias utilizadas e dos resultados obtidos com colegas e 
professores de diferentes formações, permitindo a construção de hipótese mais 
sólidas e complementares. 
Esse projeto é fruto de uma parceria entre Universidade e indústria, 
permitindo a realização de um trabalho com grande relevância científica e 
aplicabilidade técnica. Além de amplificar a discussão da problemática do 
projeto e lapidar as metodologias para responder os questionamentos 
encontrados na prática do campo, o projeto  mostrou que esta parceria traz 
benefícios para ambos os setores, público e privado, e deve ser incentivado, 
principalmente porque resolve um dos grande s problemas d a pesquisa nos 
países em desenvolvimento que é a falta de recursos materiais. 
Neste sentido, este trabalho gerou além da contribuição cientifica e 
técnica, uma visão de um vasto campo de pesquisa, com muitos 
questionamentos que podem continuar a serem explorados, sendo um ponto 
de partida para a minha carreira como pesquisadora. 
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INTRODUCTION 
Types of article 
1. Original Research Papers (Regular Papers) 
2. Review Articles 
3. Short Communications 
4. Book Reviews 
 
Original Research Papers should report the results of original research. The 
material should not have been previously published elsewhere, except in a 
preliminary form. 
 
Review Articles should cover subjects falling within the scope of the journal which 
are of active current interest. 
 
A Short Communication is a concise but complete description of a limited 
investigation, which will not be included in a later paper. Short Communications 
should be as completely documented, both by reference to the literature and 
description of the experimental procedures employed, as a regular paper. They 
should not occupy more than six printed pages (about 12 manuscript pages, 
including figures, tables and references). 
 
Book Reviews will be included in the journal on a range of relevant books which are 
not more than two years old. Book reviews will be solicited by the Book Review 
Editor. Unsolicited reviews will not usually be accepted, but suggestions for 
appropriate books for review may be sent to the Book Review Editor: 
 
Professor G. Flachowsky 
Federal Research 
Centre of Agriculture 
Institute of Animal 
Nutrition Bundesallee 
50 
D-
38116 
Braun
schwe
ig 
Germ
any 
 
Manuscripts describing the use of commercial feed products are welcome, but 
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should include the following information: major components, contents of active 
ingredients (for example enzyme activities). Independent verification, as opposed 
to a manufacturers guarantee, is always desirable and often avoids difficulties in 
the review process, especially where there are no, or few, treatment impacts. The 
Editors reserve the right to reject any manuscript employing such products, 
wherein this information is not disclosed. 
 
Submissions concerning feedstuff composition are welcome when published and/or 
accepted analytical procedures have been employed. However, unusual feedstuffs 
and/or a wide range of data are pre-requisites. 
Submissions concerning NIRS may be suitable when more accurate, precise or 
robust equations are presented. Mathematical, technical and statistical 
advancement, may constitute the foundation for acceptance. For more details see 
the editorial in Vol. 118/3-4. 
Contact details for submission 
For queries concerning the submission process or journal procedures please visit the 
Elsevier Support Center. Authors can determine the status of their manuscript 
within the review procedure using Elsevier Editorial System 
 
. 
Submission checklist 
You can use this list to carry out a final check of your submission before you send it 
to the journal for review. Please check the relevant section in this Guide for 
Authors for more details. 
 
Ensure that the following items are present: 
 
One author has been designated as the corresponding author with contact details: 
• E-mail address 
• Full postal address 
All necessary files have been uploaded: 
Manuscript: 
• Include keywords 
• All figures (include relevant captions) 
• All tables (including titles, description, footnotes) 
• Ensure all figure and table citations in the text match the files provided 
• Indicate clearly if color should be used for 
any figures in print Graphical Abstracts / 
Highlights files (where applicable) 
Supplemental files (where applicable) 
 
Further considerations 
• Manuscript has been 'spell checked' and 'grammar checked' 
• All references mentioned in the Reference List are cited in the text, and vice 
versa 
• Permission has been obtained for use of copyrighted material from other 
sources (including the Internet) 
• A competing interests statement is provided, even if the authors have no 
competing interests to declare 
• Journal policies detailed in this guide have been reviewed 
• Referee suggestions and contact details provided, based on 
journal requirements For further information, visit our Support 
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Center. 
BEFORE YOU BEGIN 
Ethics in publishing 
Please see our information pages on Ethics in publishing and Ethical guidelines for 
journal publication. 
Human and animal rights 
If the work involves the use of human subjects, the author should ensure that the 
work described has been carried out in accordance with The Code of Ethics of the 
World Medical Association (Declaration of Helsinki) for experiments involving 
humans; Uniform Requirements for manuscripts submitted to Biomedical journals. 
Authors should include a statement in the manuscript that informed consent was 
obtained for experimentation with human subjects. The privacy rights of human 
subjects must always be observed. 
 
All animal experiments should comply with the ARRIVE guidelines and should be 
carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 
and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the 
National Institutes of Health guide for the care and use of Laboratory animals (NIH 
Publications No. 8023, revised 1978) and the authors should clearly indicate in the 
manuscript that such guidelines have been followed. 
Declaration of interest 
All authors must disclose any financial and personal relationships with other people 
or organizations that could inappropriately influence (bias) their work. Examples of 
potential conflicts of interest include employment, consultancies, stock ownership, 
honoraria, paid expert testimony, patent applications/ registrations, and grants or 
other funding. If there are no conflicts of interest then please state this: 'Conflicts 
of interest: none'. More information. 
Submission declaration and verification 
Submission of an article implies that the work described has not been published 
previously (except in the form of an abstract or as part of a published lecture or 
academic thesis or as an electronic preprint, see 'Multiple, redundant or concurrent 
publication' section of our ethics policy for more information), that it is not under 
consideration for publication elsewhere, that its publication is approved by all 
authors and tacitly or explicitly by the responsible authorities where the work was 
carried out, and that, if accepted, it will not be published elsewhere in the same 
form, in English or in any other language, including electronically without the 
written consent of the copyright-holder. To verify originality, your article may be 
checked by the originality detection service CrossCheck. 
Changes to authorship 
Authors are expected to consider carefully the list and order of authors before 
submitting their manuscript and provide the definitive list of authors at the time of 
the original submission. Any addition, deletion or rearrangement of author names 
in the authorship list should be made only 
before the manuscript has been accepted and only if approved by the journal 
Editor. To request such a change, the Editor must receive the following from the 
corresponding author: (a) the reason  for the change in author list and (b) 
written confirmation (e-mail, letter) from all authors that they agree with the 
addition, removal or rearrangement. In the case of addition or removal of authors, 
this includes confirmation from the author being added or removed. 
Only in exceptional circumstances will the Editor consider the addition, deletion or 
rearrangement of authors after the manuscript has been accepted. While the 
Editor considers the request, publication of the manuscript will be suspended. If the 
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manuscript has already been published in an online issue, any requests approved 
by the Editor will result in a corrigendum. 
Copyright 
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing 
Agreement' (see more information on this). An e-mail will be sent to the 
corresponding author confirming receipt of the manuscript together with a 'Journal 
Publishing Agreement' form or a link to the online version  of this agreement. 
 
Subscribers may reproduce tables of contents or prepare lists of articles including 
abstracts for internal circulation within their institutions. Permission of the 
Publisher is required for resale or distribution outside the institution and for all 
other derivative works, including compilations and translations. If excerpts from 
other copyrighted works are included, the author(s) must obtain written 
permission from the copyright owners and credit the source(s) in the article. 
Elsevier has preprinted forms for use by authors in these cases. 
 
For open access articles: Upon acceptance of an article, authors will be asked to 
complete an 'Exclusive License Agreement' (more information). Permitted third 
party reuse of open access articles is determined by the author's choice of user 
license. 
 
Author rights 
As an author you (or your employer or institution) have certain rights to reuse 
your work. More information. 
Elsevier supports responsible sharing 
Find out how you can share your research published in Elsevier journals. 
Role of the funding source 
You are requested to identify who provided financial support for the conduct of the 
research and/or preparation of the article and to briefly describe the role of the 
sponsor(s), if any, in study design; in the collection, analysis and interpretation of 
data; in the writing of the report; and in the decision to submit the article for 
publication. If the funding source(s) had no such involvement then this should be 
stated. 
Funding body agreements and policies 
Elsevier has established a number of agreements with funding bodies which allow 
authors to comply with their funder's open access policies. Some funding bodies 
will reimburse the author for the Open Access Publication Fee. Details of existing 
agreements are available online. 
After acceptance, open access papers will be published under a noncommercial 
license. For authors requiring a commercial CC BY license, you can apply after your 
manuscript is accepted for publication. 
Open access 
This journal offers authors a choice in publishing their research: 
 
Open access 
• Articles are freely available to both subscribers and the wider public with 
permitted reuse. 
• An open access publication fee is payable by authors or on their behalf, e.g. by 
their research funder or institution. 
Subscription 
• Articles are made available to subscribers as well as developing countries and 
patient groups through our universal access programs. 
• No open access publication fee payable by authors. 
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Regardless of how you choose to publish your article, the journal will apply the 
same peer review criteria and acceptance standards. 
For open access articles, permitted third party (re)use is defined by the following 
Creative Commons user licenses: 
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) 
For non-commercial purposes, lets others distribute and copy the article, and to 
include in a collective work (such as an anthology), as long as they credit the 
author(s) and provided they do not alter or modify the article. 
The open access publication fee for this journal is USD 2500, excluding taxes. 
Learn more about Elsevier's pricing policy: 
http://www.elsevier.com/openaccesspricing. 
Green open access 
Authors can share their research in a variety of different ways and Elsevier has a 
number of     green open access options available. We recommend authors see our 
green open access page for further information. Authors can also self-archive their 
manuscripts immediately and enable public access from their institution's 
repository after an embargo period. This is the version that has been accepted for 
publication and which typically includes author-incorporated changes suggested 
during submission, peer review and in editor-author communications. Embargo 
period: For subscription articles, an appropriate amount of time is needed for 
journals to deliver value to subscribing customers before an article becomes freely 
available to the public. This is the embargo period and it begins from the date the 
article is formally published online in its final and fully citable form. Find out more. 
This journal has an embargo period of 12 months. 
Elsevier Publishing Campus 
The Elsevier Publishing Campus (www.publishingcampus.com) is an online 
platform offering free lectures, interactive training and professional advice to 
support you in publishing your research. The College of Skills training offers 
modules on how to prepare, write and structure your article and explains how 
editors will look at your paper when it is submitted for publication. Use these 
resources, and more, to ensure that your submission will be the best that you can 
make it. 
Language (usage and editing services) 
Please write your text in good English (American or British usage is accepted, but 
not a mixture of these). Authors who feel their English language manuscript may 
require editing to eliminate possible grammatical or spelling errors and to conform 
to correct scientific English may wish to use the English Language Editing service 
available from Elsevier's WebShop. 
Submission 
Our online submission system guides you stepwise through the process of entering 
your article details and uploading your files. The system converts your article files 
to a single PDF file used in the peer-review process. Editable files (e.g., Word, 
LaTeX) are required to typeset your article for final publication. All 
correspondence, including notification of the Editor's decision and requests for 
revision, is sent by e-mail. 
Poorly written and/or presented manuscripts (relative to the journal's guidelines) 
may be returned to authors for upgrading by the editorial office, prior to a review 
for scientific merit. 
Before preparing their manuscript, it is suggested that authors examine the 
editorial by the Editors- in-Chief in Vol. 134/3-4, which outlines several practices 
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and strategies of manuscript preparation that the Editors-in-Chief have found to be 
successful. This editorial also outlines practices that can lead to difficulties with 
reviewers and/or rejection of the manuscript for publication. There is also an 
example of an Animal Feed Science and Technology manuscript available on the 
journal website at http://www.elsevier.com/locate/anifeedsci. 
Submit your article 
Please submit your article via https://www.evise.com/evise/jrnl/ANIFEE. 
Referees 
Please submit the names and institutional e-mail addresses of several potential 
referees. For more details, visit our Support site. Note that the editor retains the 
sole right to decide whether or not the suggested reviewers are used. 
PREPARATION 
Peer review 
This journal operates a single blind review process. All contributions will be initially 
assessed by the editor for suitability for the journal. Papers deemed suitable are 
then typically sent to a minimum of two independent expert reviewers to assess the 
scientific quality of the paper. The Editor is responsible for the final decision 
regarding acceptance or rejection of articles. The Editor's decision is final. More 
information on types of peer review. 
Use past tense for current findings, and the present tense for "truths" and 
hypotheses. 
Article Structure 
Manuscripts should have numbered lines, with wide margins and double 
spacing throughout, i.e. also for abstracts, footnotes and references. Every page 
of the manuscript, including the title page, references, tables, etc., should 
be numbered continuously. However, in the text no reference should be made to 
page numbers; if necessary, one may refer to sections. Avoid excessive usage of 
italics to emphasize part of the text. 
Introduction 
State the objectives of the work and provide an adequate background, avoiding a 
detailed literature survey or a summary of the results. 
Material and methods 
Provide sufficient detail to allow the work to be reproduced. Methods already 
published should be indicated by a reference: only relevant modifications should 
be described. 
If reference is made to AOAC, ISO or similar analytical procedure(s), the specific 
procedure identification number(s) must be cited. A number of references for 
neutral and acid detergent fibre (NDF, ADF) assays exist, and an alternative 
reference to the now out-of-print USDA Agriculture Handbook 379 must be used. 
There are many options for NDF and ADF assays (e.g. sodium sulfite, alpha 
amylase, residual ash), which must be specified in the text. For more details see 
the editorial in Vol. 118/3-4. 
 
The following definitions should be used, as appropriate: 
a. aNDFom-NDF assayed with a heat stable amylase and expressed exclusive of 
residual ash. 
b. NDFom-NDF not assayed with a heat stable amylase and expressed exclusive of 
residual ash. 
c. aNDF-NDF assayed with a heat stable amylase and expressed inclusive of 
residual ash. 
d. NDF-NDF assayed without a heat stable amylase and expressed inclusive of 
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residual ash. 
e. ADFom-ADF expressed exclusive of residual ash. 
f. ADF-ADF expressed inclusive of residual ash. 
g. Lignin (sa)-Lignin determined by solubilization of cellulose with sulphuric acid. 
h. Lignin (pm)-Lignin determined by oxidation of lignin with permanganate. 
 
While expressions of NDF and ADF inclusive of residual ash will continue to be 
acceptable (i.e., the terms aNDF, NDF and ADF above), the Editors-in-Chief highly 
recommend reporting all fibre values, including digestibilities, on an OM basis. 
Silica is partially soluble in ND, is quantitatively recovered in AD, and so may 
contribute to the 'fibre' values and to subsequent digestibility coefficients. 
 
Reporting 'hemicellulose' values as the difference between NDF and ADF is 
generally only acceptable if the analyses have been sequential on the same 
sample. Crude fibre (CF), nitrogen-free extract (NFE) and total digestible nutrients 
(TDN) are not acceptable terms for describing feeds and should only be referred to 
in a historical context. 
Results 
Results should be clear and concise. 
Discussion 
This should explore the significance of the results of the work, not repeat them. 
Avoid extensive citations and discussion of published literature. Combined 'Results 
and Discussion' sections are only acceptable for 'Short Communications', except 
under compelling circumstances. 
Conclusions 
The main conclusions of the study may be presented in a short Conclusions section, 
which may stand alone or form a subsection of a Discussion or Results and 
Discussion section. 
Essential title page information 
• Title. Concise and informative. Titles are often used in information-retrieval 
systems. Avoid abbreviations and formulae where possible. 
• Author names and affiliations. Please clearly indicate the given name(s) and 
family name(s)  of each author and check that all names are accurately spelled. 
Present the authors' affiliation addresses (where the actual work was done) below 
the names. Indicate all affiliations with a lower- case superscript letter 
immediately after the author's name and in front of the appropriate address. 
Provide the full postal address of each affiliation, including the country name and, 
if available, the e-mail address of each author. 
• Corresponding author. Clearly indicate who will handle correspondence at all 
stages of refereeing and publication, also post-publication. Ensure that the e-
mail address is given and that contact details are kept up to date by the 
corresponding author. 
• Present/permanent address. If an author has moved since the work 
described in the article was done, or was visiting at the time, a 'Present address' 
(or 'Permanent address') may be indicated as a footnote to that author's name. 
The address at which the author actually did the work must be retained as the 
main, affiliation address. Superscript Arabic numerals are used for such footnotes. 
Abstract 
The abstract should be clear, descriptive and not longer than 400 words. It should 
contain the following specific information: purpose of study; experimental 
treatments used; results obtained, preferably with quantitative data; significance 
of findings; conclusions; implications of results if appropriate. 
Graphical abstract 
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Although a graphical abstract is optional, its use is encouraged as it draws more 
attention to the online article. The graphical abstract should summarize the contents 
of the article in a concise, pictorial form designed to capture the attention of a wide 
readership. Graphical abstracts should be submitted as a separate file in the online 
submission system. Image size: Please provide an image with a minimum of 531 
× 1328 pixels (h × w) or proportionally more. The image should be readable at a 
size of 5 × 13 cm using a regular screen resolution of 96 dpi. Preferred file types: 
TIFF, EPS, PDF or MS Office files. You can view Example Graphical Abstracts on our 
information site. 
Authors can make use of Elsevier's Illustration Services to ensure the best 
presentation of their images and in accordance with all technical requirements. 
Highlights 
Highlights are mandatory for this journal. They consist of a short collection of 
bullet points that convey the core findings of the article and should be submitted in 
a separate editable file in the online submission system. Please use 'Highlights' in 
the file name and include 3 to 5 bullet points (maximum 85 characters, including 
spaces, per bullet point). You can view example Highlights on our information site. 
Keywords 
Immediately after the abstract, provide a maximum of 6 keywords, using 
American spelling and avoiding general and plural terms and multiple concepts 
(avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations 
firmly established in the field may be eligible. These keywords will be used for 
indexing purposes. 
Abbreviations 
Define abbreviations that are not standard in this field in a footnote to be placed 
on the first page  of the article. Such abbreviations that are unavoidable in the 
abstract must be defined at their first mention there, as well as in the footnote. 
Ensure consistency of abbreviations throughout the article. 
Acknowledgements 
Collate acknowledgements in a separate section at the end of the article before the 
references and do not, therefore, include them on the title page, as a footnote to 
the title or otherwise. List here those individuals who provided help during the 
research (e.g., providing language help, writing assistance or proof reading the 
article, etc.). 
Formatting of funding sources 
List funding sources in this standard way to facilitate compliance to funder's 
requirements: 
 
Funding: This work was supported by the National Institutes of Health [grant 
numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant 
number zzzz]; and the United States Institutes of Peace [grant number aaaa]. 
  
102 
 
 
It is not necessary to include detailed descriptions on the program or type of grants 
and awards. When funding is from a block grant or other resources available to a 
university, college, or other research institution, submit the name of the institute 
or organization that provided the funding. 
 
If no funding has been provided for the research, please include the following 
sentence: 
 
This research did not receive any specific grant from funding agencies in the 
public, commercial, or not-for-profit sectors. 
Nomenclature and units 
Follow internationally accepted rules and conventions: use the international 
system of units (SI). If other quantities are mentioned, give their equivalent in SI. 
You are urged to consult IUB: Biochemical Nomenclature and Related Documents 
for further information. 
Authors and Editors are, by general agreement, obliged to accept the rules 
governing biological nomenclature, as laid down in the International Code of 
Botanical Nomenclature, the International Code of Nomenclature of Bacteria, and 
the International Code of Zoological Nomenclature. All biotica (crops, plants, 
insects, birds, mammals, etc.) should be identified by their scientific names when 
the English term is first used, with the exception of common domestic animals. All 
biocides and other organic compounds must be identified by their Geneva names 
when first used in the text. Active ingredients of all formulations should be likewise 
identified. 
 
SI or SI-derived units should be used throughout (e.g. MJ and not Kcal for energy 
concentrations). Concentrations should be expressed on a 'per kg' basis (w/w); 
however, w/v, v/v, mol/mol or M may be accepted depending on the circumstances. 
In addition, 'units' and 'equivalents' are acceptable. Normality should be avoided, 
as it may be ambiguous for certain acids. If analytical standards have been used, 
they should be specified by name (e.g. yeast RNA) and form (e.g. lactose 
monohydrate). Percents should only be used when describing a relative increase or 
decrease in a response. Proportions should be maximum 1.0 or ≤1.0. For more 
details see the editorial in Vol. 118/3-4. 
 
Percent is only used to indicate relative changes. For composition, both w/w (often 
solids composition g/kg) and w/v (e.g. g/L), v/v (e.g. m/L), mol/mol or M can be 
accepted depending on the circumstances. Specify units (e.g. g/L) and never as 
percent. 
 
Digestibility/metabolisability and degradability should always be expressed as a 
coefficient (not %), and the content of, for example, the digestible component 
should be expressed as g/kg: thus, the coefficient of digestibility of dry matter is 
0.8, while the content of digestible dry matter is 800g/ kg. A distinction between 
true and apparent digestibility should be made, as well as between faecal and ileal 
(e.g. coefficient of total tract apparent digestibility - CTTAD). The terms 
'availability' and 'bioavailability' should be avoided without definition in context. 
 
In chemical formulae, valence of ions should be given as, e.g. Ca2+, not as Ca++. 
Isotope numbers should precede the symbols e.g. 18O. The repeated use of 
chemical formulae in the text is to be avoided where reasonably possible; instead, 
the name of the compound should be given in full. Exceptions may be made in the 
case of a very long name occurring very frequently or in the case  of a compound 
being described as the end product of a gravimetric determination (e.g. phosphate 
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as P2O5). 
Math formulae 
Please submit math equations as editable text and not as images. Present simple 
formulae in      line with normal text where possible and use the solidus (/) instead 
of a horizontal line for small fractional terms, e.g., X/Y. In principle, variables are 
to be presented in italics. Powers of e are often more conveniently denoted by exp. 
Number consecutively any equations that have to be displayed separately from the 
text (if referred to explicitly in the text). 
If differences between treatments are statistically significant, this should be 
indicated by adding the actual 'P' value obtained. If 0.10 > P > 0.05, then 
differences can be considered to suggest a trend, or tendency, to a difference, but 
the actual 'P' value should be stated. Further information on this issue can be 
found in Animal Feed Science and Technology Vol. 129/1-2. 
Spaces should be used between all values and units, except for the following: 
Between the value and degrees or percent. In equations around * and /. In 
probability expressions (P<0.05). When probability values are given, the 'P' should 
be a capital letter. 
• Make sure you use uniform lettering and sizing of your original artwork. 
• Embed the used fonts if the application provides that option. 
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New 
Roman, Symbol, or use fonts that look similar. 
• Number the illustrations according to their sequence in the text. 
• Use a logical naming convention for your artwork files. 
• Provide captions to illustrations separately. 
• Size the illustrations close to the desired dimensions of the published version. 
• Submit each illustration as a separate file. 
A detailed guide on electronic artwork is available. 
You are urged to visit this site; some excerpts from the detailed information 
are given here. 
Formats 
If your electronic artwork is created in a Microsoft Office application (Word, 
PowerPoint, Excel) then please supply 'as is' in the native document format. 
Regardless of the application used other than Microsoft Office, when your 
electronic artwork is finalized, please 'Save as' or convert the images to one of the 
following formats (note the resolution requirements for line drawings, halftones, 
and line/halftone combinations given below): 
EPS (or PDF): Vector drawings, embed all used fonts. 
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 
300 dpi. 
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a 
minimum of 1000 dpi. TIFF (or JPEG): Combinations bitmapped line/half-tone 
(color or grayscale), keep to a minimum of 500 dpi. 
Please do not: 
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these 
typically have a low number of pixels and limited set of colors; 
• Supply files that are too low in resolution; 
• Submit graphics that are disproportionately large for the content. 
All data in figures should have a measure of variation either on the plot (e.g., error 
bars), in the figure legend itself, or by reference to a table with measures of 
variation in the figure legend. 
 
Explanations should be given in the figure legend(s). Drawn text in the figures 
should be kept to a minimum. 
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If a scale is given, use bar scales (instead of numerical scales) that must be 
changed with reduction. 
Color artwork 
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), 
EPS (or PDF), or MS Office files) and with the correct resolution. If, together with 
your accepted article, you submit usable color figures then Elsevier will ensure, at 
no additional charge, that these figures will appear in color online (e.g., 
ScienceDirect and other sites) regardless of whether or not these illustrations are 
reproduced in color in the printed version. For color reproduction in print, you 
will receive information regarding the costs from Elsevier after receipt of 
your accepted article. Please indicate your preference for color: in print or online 
only. Further information on the preparation of electronic artwork. 
Tables 
Please submit tables as editable text and not as images. Tables can be placed 
either next to the relevant text in the article, or on separate page(s) at the end. 
Number tables consecutively in accordance with their appearance in the text and 
place any table notes below the table body. Be sparing in the use of tables and 
ensure that the data presented in them do not duplicate results described 
elsewhere in the article. Please avoid using vertical rules and shading in table cells. 
References 
All publications cited in the text should be presented in a list of references 
following the text of the manuscript. The manuscript should be carefully checked to 
ensure that the spelling of authors' names and dates are exactly the same in the 
text as in the reference list. The accuracy of the references  is the responsibility of 
the author(s). 
 
References published in other than the English language should be avoided, but are 
acceptable if they include an English language 'Abstract' and the number of non-
English language references cited are reasonable (in the view of the handling 
Editor) relative to the total number of references cited. 
 
In the text refer to the author's name (without initial) and year of publication, 
followed - if necessary 
- by a short reference to appropriate pages. Examples: "Since Peterson (1988) has 
shown that...". "This is in agreement with results obtained later (Kramer, 1989, 
pp. 12-16)". 
 
If reference is made in the text to a publication written by more than two authors, 
the name of the first author should be used followed by "et al.". This indication, 
however, should never be used in the list of references. In this list names of first 
author and co-authors should be mentioned. 
 
References cited together in the text should be arranged chronologically. The list of 
references should be arranged alphabetically on authors' names, and 
chronologically per author. If an author's name in the list is also mentioned with 
co-authors the following order should be used: publications of the single author, 
arranged according to publication dates - publications of the same author with one 
co- author - publications of the author with more than one co-author. Publications 
by the same author(s) in the same year should be listed as 2001a, 2001b, etc. 
Reference links 
Increased discoverability of research and high quality peer review are ensured by 
online links to  the sources cited. In order to allow us to create links to abstracting 
and indexing services, such as Scopus, CrossRef and PubMed, please ensure that 
  
105 
 
 
data provided in the references are correct. Please note that incorrect surnames, 
journal/book titles, publication year and pagination may prevent link creation. 
When copying references, please be careful as they may already contain errors. 
Use of the DOI is encouraged. 
 
A DOI can be used to cite and link to electronic articles where an article is in-press 
and full citation details are not yet known, but the article is available online. A DOI 
is guaranteed never to change, so you can use it as a permanent link to any 
electronic article. An example of a citation using DOI for an article not yet in an 
issue is: VanDecar J.C., Russo R.M., James D.E., Ambeh W.B., Franke M. (2003). 
Aseismic continuation of the Lesser Antilles slab beneath northeastern Venezuela. 
Journal  of Geophysical Research, https://doi.org/10.1029/2001JB000884. Please 
note the format of such citations should be in the same style as all other 
references in the paper. 
Web references 
As a minimum, the full URL should be given and the date when the reference was 
last accessed. Any further information, if known (DOI, author names, dates, 
reference to a source publication, etc.), should also be given. Web references can 
be listed separately (e.g., after the reference list) under a different heading if 
desired, or can be included in the reference list. 
Data references 
This journal encourages you to cite underlying or relevant datasets in your 
manuscript by citing them in your text and including a data reference in your 
Reference List. Data references should include the following elements: author 
name(s), dataset title, data repository, version (where available), year, and global 
persistent identifier. Add [dataset] immediately before the reference so we can 
properly identify it as a data reference. The [dataset] identifier will not appear in 
your published article. 
Reference management software 
Most Elsevier journals have their reference template available in many of the most 
popular reference management software products. These include all products that 
support Citation Style Language styles, such as Mendeley and Zotero, as well as 
EndNote. Using the word processor plug-ins from these products, authors only 
need to select the appropriate journal template when preparing their article, after 
which citations and bibliographies will be automatically formatted in the journal's 
style. If no template is yet available for this journal, please follow the format of the 
sample references and citations as shown in this Guide. 
Users of Mendeley Desktop can easily install the reference style for this journal by 
clicking the following link: 
http://open.mendeley.com/use-citation-style/animal-feed-science-and-technology 
When preparing your manuscript, you will then be able to select this style using 
the Mendeley plug- ins for Microsoft Word or LibreOffice. 
Reference formatting 
There are no strict requirements on reference formatting at submission. References 
can be in any style or format as long as the style is consistent. Where applicable, 
author(s) name(s), journal title/book title, chapter title/article title, year of 
publication, volume number/book chapter and the pagination must be present. 
Use of DOI is highly encouraged. The reference style used by the journal will be 
applied to the accepted article by Elsevier at the proof stage. Note that missing data 
will be highlighted at proof stage for the author to correct. If you do wish to format 
the references yourself they should be arranged according to the following 
examples: 
Reference style 
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Text: All citations in the text should refer to: 
1. Single author: the author's name (without initials, unless there is ambiguity) 
and the year of publication; 
2. Two authors: both authors' names and the year of publication; 
3. Three or more authors: first author's name followed by 'et al.' and the year of 
publication. Citations may be made directly (or parenthetically). Groups of 
references should be listed first alphabetically, then chronologically. 
Examples: 'as demonstrated (Allan, 2000a, 2000b, 1999; Allan and Jones, 1999). 
Kramer et al. (2010) have recently shown ....' 
List: References should be arranged first alphabetically and then further sorted 
chronologically if necessary. More than one reference from the same author(s) in 
the same year must be identified by the letters 'a', 'b', 'c', etc., placed after the 
year of publication. 
Examples: 
Reference to a journal publication: 
Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2010. The art of writing a 
scientific article. J. Sci. Commun. 163, 51–59. 
Reference to a book: 
Strunk Jr., W., White, E.B., 2000. The Elements of Style, fourth ed. Longman, 
New York. Reference to a chapter in an edited book: 
Mettam, G.R., Adams, L.B., 2009. How to prepare an electronic version of your 
article, in: Jones, B.S., Smith , R.Z. (Eds.), Introduction to the Electronic Age. E-
Publishing Inc., New York, pp. 281–304. 
Reference to a website: 
Cancer Research UK, 1975. Cancer statistics reports for the UK. 
http://www.cancerresearchuk.org/ aboutcancer/statistics/cancerstatsreport/ 
(accessed 13.03.03). 
Reference to a dataset: 
[dataset] Oguro, M., Imahiro, S., Saito, S., Nakashizuka, T., 2015. Mortality data 
for Japanese oak wilt disease and surrounding forest compositions. Mendeley Data, 
v1. https://doi.org/10.17632/ xwj98nb39r.1. 
References concerning unpublished data and "personal communications" should 
not be cited in the reference list but may be mentioned in the text. 
Journal abbreviations source 
Journal names should be abbreviated according to the List of Title Word 
Abbreviations. 
Video 
Elsevier accepts video material and animation sequences to support and enhance 
your scientific research. Authors who have video or animation files that they wish 
to submit with their article are strongly encouraged to include links to these within 
the body of the article. This can be done in the same way as a figure or table by 
referring to the video or animation content and noting in the body text where it 
should be placed. All submitted files should be properly labeled so that they 
directly relate to the video file's content. In order to ensure that your video or 
animation material is directly usable, please provide the files in one of our 
recommended file formats with a preferred maximum size of 150 MB in total. Any 
single file should not exceed 50 MB. Video and animation files supplied will be 
published online in the electronic version of your article in Elsevier Web products, 
including ScienceDirect. Please supply 'stills' with your files: you can choose any 
frame from the video or animation or make a separate image. These will be used 
instead of standard icons and will personalize 
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the link to your video data. For more detailed instructions please visit our video 
instruction pages. Note: since video and animation cannot be embedded in the 
print version of the journal, please provide text for both the electronic and the 
print version for the portions of the article that refer to this content. 
Supplementary material 
Supplementary material such as applications, images and sound clips, can be 
published with your article to enhance it. Submitted supplementary items are 
published exactly as they are received (Excel or PowerPoint files will appear as such 
online). Please submit your material together with the article and supply a concise, 
descriptive caption for each supplementary file. If you wish to make changes to 
supplementary material during any stage of the process, please make sure to 
provide an updated file. Do not annotate any corrections on a previous version. 
Please switch off the 'Track Changes' option in Microsoft Office files as these will 
appear in the published version. 
RESEARCH DATA 
This journal encourages and enables you to share data that supports your research 
publication where appropriate, and enables you to interlink the data with your 
published articles. Research data refers to the results of observations or 
experimentation that validate research findings. To facilitate reproducibility and 
data reuse, this journal also encourages you to share your software, code, models, 
algorithms, protocols, methods and other useful materials related to the project. 
 
Below are a number of ways in which you can associate data with your article or 
make a statement about the availability of your data when submitting your 
manuscript. If you are sharing data in one of these ways, you are encouraged to cite 
the data in your manuscript and reference list. Please refer to the "References" 
section for more information about data citation. For more information on depositing, 
sharing and using research data and other relevant research materials, visit the 
research data page. 
Data linking 
If you have made your research data available in a data repository, you can link your 
article directly to the dataset. Elsevier collaborates with a number of repositories to 
link articles on ScienceDirect with relevant repositories, giving readers access to 
underlying data that gives them a better understanding of the research described. 
 
There are different ways to link your datasets to your article. When available, you 
can directly link your dataset to your article by providing the relevant information in 
the submission system. For more information, visit the database linking page. 
 
For supported data repositories a repository banner will automatically appear next 
to your published article on ScienceDirect. 
 
In addition, you can link to relevant data or entities through identifiers within the 
text of your manuscript, using the following format: Database: xxxx (e.g., TAIR: 
AT1G01020; CCDC: 734053; PDB: 1XFN). 
Mendeley Data 
This journal supports Mendeley Data, enabling you to deposit any research data 
(including raw and processed data, video, code, software, algorithms, protocols, 
and methods) associated with your manuscript in a free-to-use, open access 
repository. During the submission process, after uploading your manuscript, you 
will have the opportunity to upload your relevant datasets directly to Mendeley 
Data. The datasets will be listed and directly accessible to readers next to your 
published article online. 
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For more information, visit the Mendeley Data for journals page. 
Data statement 
To foster transparency, we encourage you to state the availability of your data in 
your submission. This may be a requirement of your funding body or institution. If 
your data is unavailable to access or unsuitable to post, you will have the 
opportunity to indicate why during the submission process, for example by stating 
that the research data is confidential. The statement will appear with your 
published article on ScienceDirect. For more information, visit the Data Statement 
page. 
AudioSlides 
The journal encourages authors to create an AudioSlides presentation with their 
published article. AudioSlides are brief, webinar-style presentations that are shown 
next to the online article on ScienceDirect. This gives authors the opportunity to 
summarize their research in their own words and to help readers understand what 
the paper is about. More information and examples are available. Authors of this 
journal will automatically receive an invitation e-mail to create an AudioSlides 
presentation after acceptance of their paper. 
Virtual Microscope 
The journal encourages authors to supplement in-article microscopic images with 
corresponding high resolution versions for use with the Virtual Microscope viewer. 
The Virtual Microscope is a web based viewer that enables users to view 
microscopic images at the highest level of detail and provides features such as 
zoom and pan. This feature for the first time gives authors the opportunity to 
share true high resolution microscopic images with their readers. More information 
and examples. Authors of this journal will receive an invitation e-mail to create 
microscope images for use with  the Virtual Microscope when their manuscript is 
first reviewed. If you opt to use the feature, please contact 
virtualmicroscope@elsevier.com for instructions on how to prepare and upload the 
required high resolution images. 
Additional Information 
Authors should use the 'Track Changes' option when revising their manuscripts, so 
that any changes made to the original submission are easily visible to the Editors. 
Those revised manuscripts upon which the changes are not clear may be returned 
to the author. 
 
Specific comments made in the Author Comments in response to referees' 
comments must be organised clearly. For example, use the same numbering 
system as the referee, or use 2 columns of which one states the comment and the 
other the response. 
AFTER ACCEPTANCE 
Online proof correction 
Corresponding authors will receive an e-mail with a link to our online proofing 
system, allowing annotation and correction of proofs online. The environment is 
similar to MS Word: in addition to editing text, you can also comment on 
figures/tables and answer questions from the Copy Editor. Web-based proofing 
provides a faster and less error-prone process by allowing you to directly type 
your corrections, eliminating the potential introduction of errors. 
If preferred, you can still choose to annotate and upload your edits on the PDF 
version. All instructions for proofing will be given in the e-mail we send to authors, 
including alternative methods to the online version and PDF. 
We will do everything possible to get your article published quickly and accurately. 
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Please use this proof only for checking the typesetting, editing, completeness and 
correctness of the text, tables and figures. Significant changes to the article as 
accepted for publication will only be considered at this stage with permission from 
the Editor. It is important to ensure that all corrections are sent back   to us in one 
communication. Please check carefully before replying, as inclusion of any 
subsequent corrections cannot be guaranteed. Proofreading is solely your 
responsibility. 
Offprints 
The corresponding author will, at no cost, receive a customized Share Link 
providing 50 days free access to the final published version of the article on 
ScienceDirect. The Share Link can be used   for sharing the article via any 
communication channel, including email and social media. For an extra charge, 
paper offprints can be ordered via the offprint order form which is sent once the 
article is accepted for publication. Both corresponding and co-authors may order 
offprints at any time via Elsevier's Webshop. Corresponding authors who have 
published their article open access do not receive a Share Link as their final 
published version of the article is available open access on ScienceDirect and can 
be shared through the article DOI link. 
AUTHOR INQUIRIES 
Visit the Elsevier Support Center to find the answers you need. Here you will find 
everything from Frequently Asked Questions to ways to get in touch. 
You can also check the status of your submitted article or find out when your 
accepted article will be published. 
© Copyright 2014 Elsevier | http://www.elsevier.com 
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Animal 
An International Journal of Animal Bioscience 
 
 
Instructions for authors 
Last updated September 2016 
 
 
 
 
Introduction 
 
animal – an International Journal of Animal Bioscience is a peer-reviewed journal in English, published 
monthly in both print and online formats (12 issues making a volume). Special issues or supplements 
may also be produced from time to time upon agreement with the Editorial Board. There are no page 
charges, except for reproduction of illustrations printed in colour and for the Open Access option that 
requires payment of an Article Processing charge. 
 
animal attracts the best research in animal biology and animal systems from across the spectrum of the 
agricultural, biomedical, and environmental sciences; it is the central element in a collaboration between 
the British Society of Animal Science (BSAS), the Institut National de la Recherche Agronomique 
(INRA) and the European Federation for Animal Science (EAAP) and represents the merger in 2006 of 
three scientific journals: Animal Science; Animal Research; Reproduction, Nutrition, Development. 
 
Scope 
 
animal publishes original cutting-edge research, horizon-scanning reviews, and opinion papers on 
animal-related aspects of the life sciences at the molecular, cellular, organ, whole animal and production 
system levels. It is essential reading for all animal scientists interested in biochemistry, microbiology, 
nutrition, physiology, modelling, genetics, behaviour, immunology, epidemiology, economics, 
sociology, food science and technology, human health, farming systems, and land-use management, 
environmental impact and climate change. 
 
Papers will be considered in aspects of both strategic and applied science in the areas of Animal 
Breeding and Genetics, Nutrition, Physiology and Functional Biology of Systems, Behaviour, Health and 
Welfare, Livestock Farming Systems and Environment, and Product Quality, Human Health and Well-
being. Emphasis is placed on managed and farm animals and on the integrative nature of biological 
systems. The use of laboratory animal models for the benefit of farmed livestock is within  the scope. 
Studies using farm animals with the aim of improving human health are also acceptable if they indicate 
obvious benefits to farmed livestock. Wild animals which are marginally bred in a few countries or 
which could be bred in the future, and wild animals raised in captivity are not in scope. Papers dealing 
with the translation of basic and strategic science into whole animal, and livestock system, impacts on 
productivity, product quality, the environment and humans (health, nutrition and well-being) will be 
welcome, as are methodology papers. Papers should be of international relevance, appeal to an 
international readership and not limited to national or regional conditions. The full scope of the journal 
should be consulted on http://www.animal-journal.eu/scope.htm before submitting a paper. 
 
General specifications for different types of article 
 
Submitted manuscripts should not have been published previously, except in a limited form (e.g. short 
communication to a symposium or as part of MSc or PhD theses) and should not be under  consideration 
for publication by other journals. Book reviews are not accepted. 
 
All co-authors should agree with the content of the manuscript. Authors must have obtained permission 
to use any copyrighted material in the manuscript prior to submission. The work described in the 
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manuscript must comply with ethical guidelines available on the website http://www.animal- 
journal.eu/ethical_policy.htm and be reported according to "The ARRIVE Guidelines for Reporting 
Animal Research" detailed in Kilkenny et al. (2010)1 and summarised at www.nc3rs.org.uk. 
 
animal publishes different types of articles: 
 
Research articles 
They correspond to a full account of a complete project. The approach can be experimental or 
theoretical, provided the work has been carried out in a systematic way. Routine studies, descriptive 
experiments without an experimental design controlled by the author, papers based on repetition of 
published experiments with other breeds, or in other geographical conditions are discouraged. Articles 
presenting a detailed description of a new technique are within the scope. Comparison of existing 
methods is considered, provided similar comparisons have never been published. Research articles, 
including meta-analyses, should be comprehensive and should include an in-depth discussion. Papers  in 
a numbered series are not accepted unless all are submitted at the same time. 
 
Short communications 
Short communications present exceptionally exciting, novel or timely contents. animal publishes a 
limited number of short communications. Their submission will only be accepted based on Editor’s 
judgement, and they will be peer-reviewed in the same way as research papers. Partial data or complete 
studies with a limited amount of results will not be considered as short communications, and will be 
handled as research papers. 
 
Review articles 
They are invited by the Editorial Board or unsolicited. Review articles have to be contemporary and 
comprehensive, and add information to published reviews on the same topic; if not the case, they will 
be rejected immediately by the Editor-in-Chief. Sharp critical analyses of novel data or concepts are 
encouraged. When relevant, a statistical analysis of data and a meta-analysis approach are 
recommended (but meta-analyses only are not considered as review articles). Authors of unsolicited 
review articles are encouraged to question the Editorial Office prior to submission through 
questions@animal-journal.eu to ask if their paper is within the scope and of interest to the journal. 
 
Invited Opinion papers 
They are submitted by invitation of the Management Board of animal journal only and are published as 
open access papers. They are short papers, which aim to inform scientists, industry, the public and policy 
makers about cutting-edge issues in research or the impact of research. They reflect the opinion of their 
authors who bear full responsibility of the published paper. 
 
Conference/Symposium papers 
The journal will consider for publication the results of original work and critical reviews that are 
presented at conferences/symposia. Symposium organisers who wish to publish bundles of papers from a 
symposium/conference in animal should first contact the Editor-in-Chief of animal journal 
(questions@animal-journal.eu) for agreement and information on the management of these papers. If the 
papers do not fit the requested conditions for publication in animal, the papers may be referred to 
Advances in Animal Biosciences, a companion publication of animal published by Cambridge University 
Press. Acceptance of such papers will be subject to: 
* the content being within the scope of the journal 
* the journal standard peer review process 
 
 
 
 
 
 
 
 
 
1 Kilkenny C, Browne WJ, Cuthill IC, Emerson M and Altman DG 2010. Improving bioscience research 
reporting: The ARRIVE guidelines for reporting animal research. PLoS Biology 8, e1000412. doi: 
10.1371/journal.pbio.1000412. 
  
113 
 
 
Table 1 Specifications for the different types of article 
 
Article type Maximum length 
(all text except 
figures) 
Maximum 
number of 
tables plus 
figures 
Maximum 
number of 
references 
Additional information 
Original research 7 000 words 
(equivalent to 9 
pages in journal) 
8 35  
Short communications 3 000 words 3 10  
Reviews 9 500 words 
(equivalent to 12 
journal pages) 
10 50  
Opinion papers 1700 words 
(equivalent to 2 
journal pages) or 1 
200 if a figure is 
submitted 
1 5  
All article types   5 references 
per 1000 words 
Supplementary material 
can be proposed and will 
be made available 
  online  
 
 
Recommendations for preparation of papers 
 
The responsibility for the preparation of a paper in a form suitable for publication lies with the 
author. Authors should consult a free issue or a free article of animal, available at 
https://www.cambridge.org/core/journals/animal, in order to make themselves broadly familiar with the 
layout and style of animal. A style sheet summarising these indications is available on our website at 
http://www.animal-journal.eu/documents/Animal_style_template.doc. 
 
Before submitting your manuscript, we strongly recommend that you consult the pre-submission 
checklist. Manuscripts that do not comply with the directions or that are too long will not be 
accepted for peer-review. This will ensure that they are judged at peer review exclusively on academic 
merit. Any deviations from these recommendations will be at the discretion of the Editor-in- Chief. 
 
English 
A good quality of written English is required. Spelling may be in British or American English but must be 
consistent throughout the paper. Care should be exercised in the use of agricultural terminology that is ill-
defined or of local familiarity only. If the English is not good enough, the manuscript will be sent back to 
the authors. Cambridge University Press recommends that authors have their manuscripts checked by an 
English language native speaker before submission. We list a number of third-party services specialising 
in language editing and / or translation at: https://www.cambridge.org/core/services/authors/language-
services and suggest that authors contact them as appropriate. Use of any of these services is at the 
author's own expense. The copy-editor will not perform language editing. 
 
Manuscript layout 
Manuscripts should be prepared using a standard word processing programme, and presented in a clear 
readable format with easily identified sections and headings. A style sheet is available on our website at 
http://www.animal-journal.eu/documents/Animal_style_template.doc. 
 
Manuscript layout directions 
 Typed with double-line spacing with wide margins (2.5 cm) 
 The lines must be continuously numbered; the pages must also be numbered 
 Font Arial 12 should be used for the text, and Arial 11 for tables and references 
 The sections should typically be assembled in the following order: Title, Authors, 
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Authors' full affiliations including department and post/zip codes, Corresponding author, Short title, 
Abstract, Keywords, Implications, Introduction, Material and methods, Results, Discussion, 
Acknowledgements, References, Tables, List of figure captions 
 The use of small paragraphs with less than 6 to 8 lines must be avoided 
 Footnotes in the main text are to be avoided 
 The manuscript complies with the section specific requirements set out below 
 
Full title 
The title needs to be concise and informative. It should: 
(a) arrest the attention of a potential reader scanning a journal or a list of titles; 
(b) provide sufficient information to allow the reader to judge the relevance of a paper to his/her 
interests; 
(c) incorporate keywords or phrases that can be used in indexing and information retrieval,   especially 
the animal species on which the experiment has been carried out; 
(d) avoid inessentials such as ‘A detailed study of ...’, or ‘Contribution to ...’; 
(e) not include the name of the country or of the region where the experiment took place; 
(f) not include Latin names if there is a common name, or abbreviations. 
 
Full title directions 
 No more than 170 characters including spaces 
 Include "Review:", "Invited review:" or "Animal board invited review:" before the full 
title if required (see above) 
 The title of an invited opinion paper should start with "Opinion paper:" 
 The title of a short communication should start with "Short communication:" 
 
Authors and affiliations 
The names and affiliations of the authors should be presented as follows: 
Example 
J. Smith1,a, P.E. Jones2, J.M. Garcia1,3 and P.K. Martin Jr2  [initials only for first names] 
1Department of Animal Nutrition, Scottish Agricultural College, West Main Road, Edinburgh EH9 3JG, UK 
2
Animal Science Department, North Carolina State University, Raleigh, NC 27695-7621, USA 
3
Laboratorio de Producción Animal, Facultad de Veterinaria, Universidad de Zaragoza, C. Miguel Servet, 177, 
50013, Zaragoza, Spain 
 
a
Present address: Dairy Science Laboratory, AgResearch, Private Bag 11008, Palmerston North, New Zealand (for 
any author of the list whose present address differs from that at which the work was done) 
 
Corresponding author: John Smith. E-mail: John.Smith@univ.co.uk. 
 
The corresponding author who submits and manages the manuscript during the submission/review 
process will need to be registered on Editorial Manager. He or she can be different from the 
corresponding author indicated in the manuscript who will be the correspondent for  the  published 
paper. 
 
Short title (max 50 characters including spacing) 
Authors should provide a short title (after the corresponding author line) with the same specifications  as 
the full title for use as a running head. If the short title is not appropriate, it could be modified by the 
Editorial Office, with the author’s agreement. 
 
Abstract (max 400 words, single paragraph) 
The abstract should be complete and understandable without reference to the paper. It is important to 
attract the attention of potential readers. The context and the rationale of the study are presented 
succinctly to support the objectives. The experimental methods and main results are summarised but 
should not be overburdened by numerical values or probability values. The abstract ends with a short and 
clear conclusion. Citations, references to tables and figures are not acceptable. Abbreviations used in the 
abstract have to be defined in the abstract. 
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Keywords 
Keywords are essential in information retrieval and should complement the title with respect to indicating 
the subject of the paper. 
 
Keyword directions 
 Five keywords 
 Keywords should be short and specific 
 If not in the title, the animal species or type is among the keywords 
 The use of non-standard abbreviations in the list of keywords is discouraged 
 
Implications (max 100 words) 
Implications must explain the expected impact that the results may have on practice when they will be 
applied. Impact may be economic, environmental and/or social. Implications should not be limited to 
presenting the context and objectives, and should not be an "abstract of the abstract". This is written in 
simple English suitable for non-specialists or even non science readers. The use of non-standard 
abbreviations is discouraged. 
 
Introduction 
The introduction briefly outlines the context of the work, presents the current issues that the authors are 
addressing and the rationale to support the objectives, and clearly defines the objectives. For hypothesis 
driven research, the hypothesis under test should be clearly stated. Increasing the knowledge on a subject 
is not an objective per se. 
 
Material and methods 
Material and methods should be described in sufficient detail so that it is possible for others to repeat the 
experiment. Reference to previously published work may be used to give methodological details, 
provided that said publications are readily accessible and in English. 
 
If a proprietary product is used as a source of material in experimental comparisons, this should be 
described using the appropriate chemical name. If the trade name is helpful to the readers, provide it in 
parentheses after the first mention. Authors who have worked with proprietary products, including 
equipment, should ensure that the manufacturers or suppliers of these products have no objections to 
publication if the products, for the purpose of experimentation, were not used according to the 
manufacturer’s instructions. 
 
Statistical analysis of results 
The statistical analysis of results should be presented in a separate sub-section of the "Material and 
methods" section. The statistical design and the models of statistical analysis must be described, as well 
as each of the statistical methods used. Sufficient statistical details must be given to allow replication of 
the statistical analysis. The experimental unit should be defined (e.g. individual animal, group of 
animals). Generally, an analysis of variance is preferred to a simple t-test. A statistical guide for  authors 
is available on the website at http://www.animal-journal.eu/statistical_instructions.htm. The publication 
of Lang and Altman (2013)2 can also be used as a reference. 
 
Statistics directions 
 In the text, the level of significance attained is indicated by the following conventional 
standard abbreviations (which need not be defined): P > 0.05 for non-significance and P < 
0.05, P < 0.01 and P < 0.001 for significance at these levels. Exact level of statistical 
significance (e.g. P = 0.07) can also be used 
 When data are analysed by analysis of variance, a residual error term, such as the 
pooled standard error, the residual standard deviation (RSD) or the root mean square error 
(RMSE) is given for each criteria/item/variable/trait in a separate column (or line) 
 Treatment means are reported with meaningful decimals. For guidance, the last digit 
corresponds to 1/10 of standard error 
 
2 
Lang T and Altman D 2013. Basic statistical reporting for articles published in clinical medical journals: the 
SAMPL guidelines. In Science editors' handbook (ed. Smart P, Maisonneuve H and Polderman A), pp. 175-182. 
European Association of Science Editors, Exeter, UK. This document may be reprinted without charge but must 
include the original citation. 
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 In tables, statistical significance is indicated in a separate column.     The P values (e.g. 
P = 0.07) are reported or levels of significance are indicated by *, ** and *** for P < 0.05, P < 
0.01 and P < 0.001, respectively 
 In tables, differences between treatments (or comparison of mean values) are indicated 
using superscript letters with the following conventional standard: a, b for P < 0.05; A, B for P 
< 0.01; in most cases, the 0.05 level is sufficient 
 
Results - Discussion 
Separation between Results and Discussion is preferred to highlight the interpretation of results. 
Presentation of Results and Discussion in a single section is possible but discouraged. 
 
Acknowledgements 
In this section, the authors may acknowledge (briefly) their support staff, their funding sources (with 
research funder and/or grant number), their credits to companies or copyrighted material, etc. All papers 
with a potential conflict of interest must include a description/explanation under the Acknowledgements 
heading. 
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List of references. Literature cited should be listed in alphabetical order by authors' names and 
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Book directions 
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Book chapter directions 
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Wallingford, UK. 
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are provided; commas between authors; "and" before the last author where there are two or 
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Proceedings/Conference papers directions 
 References from proceedings or conference papers are formatted as follows: 
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 The list of authors and publication years are written as for journal articles (all   authors 
are provided; commas between authors; "and" before the last author where there are two or 
more authors; full stops after publication years) 
Example 
o Author A, Author B, Author CD and Author E Year. 
 No capitals for paper titles except initial capital of the first word and words that 
ordinarily take capitals 
 Conference dates are provided in the format: DD Month YYYY, e.g. 10 August 2014 
 Conference locations are given and listed as: 
City, State (2-letter abbreviation) for US places, Country. 
Examples 
o Champaign, IL, USA. 
o Cambridge, UK. 
o Versailles, France. 
o Geneva, Switzerland. 
 
Website directions 
 References from websites are formatted as follows: 
Author(s)/Institution Year. Document/Page title. Retrieved on DD Month YYYY (i.e. 
accessed date) from http://www.web-page address (URL). 
Examples 
o Bryant P 1999. Biodiversity and Conservation. Retrieved on 4 October 1999, from 
http://darwin.bio.uci.edu/~sustain/bio65/Titlpage.htm 
 The list of author name(s) and publication years are written as for journal articles (all 
authors are provided; commas between authors; "and" before the last author where there are 
two or more authors; full stops after publication years) 
Example 
o Author A, Author B, Author CD and Author E Year. 
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 No capitals for document/page titles except initial capital of the first word and words 
that ordinarily take capitals 
 Dates when documents were retrieved are included in the format: DD    Month YYYY, 
e.g. 10 August 2014 
 Web-page addresses are provided 
 
Thesis directions 
 References from theses are formatted as follows: 
Author AB Year. Thesis title. Type of thesis, University with English name, location of the 
University (i.e. City, State (2-letter abbreviation) for US places, Country). 
Example 
o Vlaeminck B 2006. Milk odd- and branched-chain fatty acids: indicators of rumen digestion for 
optimisation of dairy cattle feeding. PhD thesis, Ghent University, Ghent, Belgium. 
 The  author’s  name  and  publication  year  are  written  as  for  journal  articles      (no 
punctuation between surname and initials; full stops after publication years) 
Example 
o Author AB Year. 
 No capitals for thesis titles except initial capital of the first word and words that 
ordinarily take capitals 
 Degree levels are provided, e.g. PhD, MSc, etc. 
 University names and locations are given and listed as: 
 University name, City, State (2-letter abbreviation) for US places, Country. 
Examples: 
o Louisiana State University, Baton Rouge, LA, USA. 
o Cambridge University, Cambridge, UK. 
 
 
Tables 
Tables should be as simple as possible. The same material should not be presented in tabular and 
graphical form. An indication is given in the text where the table should be inserted. Please refer to the 
style sheet available at http://www.animal-journal.eu/documents/Animal_style_template.doc. 
 
Table directions 
 Each table is on a separate page at the end of the main text (one table per page) 
 Tables  are  typed,  preferably in double  spacing.  Single  spacing  is  possible  for long 
tables 
 Tables are numbered consecutively using Arabic numbering. They are referred to as 
Table 1, Table 2, etc., with capital ‘T’, no italics 
 Each table has its own explanatory caption. The caption is sufficient to permit the table 
to be understood without reference to the text. The animal species and the experimental 
treatments or the issue under study are indicated in each caption. The caption does not contain 
too many details about the protocol or the results 
 Tables are created in Word using the table function within the programme (without 
using tabs). Layout can be portrait or landscape 
 Large tables are discouraged in the manuscript but they may be submitted as 
Supplementary Material 
 No vertical lines between columns and no horizontal lines between rows of data 
 Generally, variables are in rows and treatments in columns 
 Column headings are concise 
 Separate columns are included to present the basic statistical results: error terms 
(preferably residual error terms) and levels of significance 
 Row items are organized with main items followed by indented sub-items in order, for 
instance, to group the criteria which share the same type of measurements or the same 
unit 
 For any (sub-)item, only the first letter of the first word is in capitals 
 Units are clearly stated either in the caption (only if a limited number of units are  
used), or for each (sub-)item. Standard abbreviations for units are used 
 Footnotes are referenced using superscript numbers 
 All abbreviations used in a table are defined as footnotes (preferred option) or in the 
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caption 
 Treatment means are reported with meaningful decimals. For guidance, the last digit 
corresponds to 1/10 of standard error 
 The number of decimals for the indicators of residual variability (RSD, SEM, RMSE 
etc.) are either identical to that chosen for mean values or have one more decimal. The choice is 
consistent in all the tables 
 See above (Statistics) for the presentation of statistical results in tables 
 
 
Figures 
Figures should be as simple as possible. The same material should not be presented in tabular and 
graphical form. An indication is given in the text where the figure should be inserted. Specific guidelines 
are provided for images (see Image Integrity and Standards). 
 
Figure directions 
 Figure captions are all listed on the same page at the end of the main text 
 All figures are numbered consecutively in the text. They are referred to as Figure 1, 
Figure 2, etc., the word ‘Figure’ being spelled out with capital ‘F’, no italics 
 Captions begin as Figure 1, Figure 2, etc. They are sufficiently detailed to allow the 
figure to be understood without reference to the text ("Figure 1 Effect of fat source and animal 
breed on carcass composition in pigs" is preferred to "Figure 1 Carcass composition"). The 
animal species and the experimental treatments or the issue under study are indicated in each 
caption. Abbreviations used in each figure have to be defined in the caption and kept to a 
minimum 
 Figures are not inserted in the text. Each figure (without caption) is uploaded  
separately with one separate file per figure and no embedded captions in these files 
 Figure size should be readable in a width of approximately 175 mm (i.e. the  maximum 
size of printing over two columns). Easy reading of the figure is required 
 Ensure that the font size is large enough to be clearly readable at the final print size 
(should not be less than 8 point, or 2.8 mm, after reduction). We recommend you use 
the following fonts: Arial, Courier, Symbol, Times, Times New Roman and ensure that they 
are consistent throughout the figures. In addition, ensure that any fonts used to create or label 
figures are embedded if the application provides that option 
 Symbols and line types should allow different elements to be easily distinguished 
(generally, solid symbols are used before open symbols, and continuous lines before 
dotted or dashed lines) 
 Figures are usually supplied as black and white 
 Colours  can  be  used  in  figures  if  they  are  essential  to  understanding  the  figure. 
Publication charges are made for colour figures. The cost for reproducing figures in colour 
within the printed issue is £200.00 / $320.00 per figure 
 If figures are to be printed in colour, use CMYK (instead of RGB) colour mode 
preferably 
 The figures should preferably be provided as TIFF or EPS files. Other formats such  as 
MS Word, MS Excel, MS PowerPoint, AI and layered PSD (up to CS3) are permitted, 
provided that figures have been originally created in these formats and that all the embedded 
artwork is at a suitable resolution. 
 The resolutions for TIFF figures at the estimated publication size must be: 
- for line figures (e.g. graphs) – 1200 dpi (6000 px for 1 column, 8400 px for 2 
columns) 
- for figures with different shadings (e.g. bar charts) – 600 dpi (3000 px for 1 
column, 4200 px for 2 columns) 
- for half tones (e.g. photographs) – 300 dpi (1500 px for 1 column, 2100 px for 
2 columns) 
 Images from the internet are unacceptable, as most of them have a resolution of only 
72 dpi 
 When your drawing/graphics application does not provide suitable ‘export’ options, 
please copy/paste or import the graphic into a Word document 
 For further information, please refer to the Cambridge Journals Artwork Guide, which 
can be found online at: http://journals.cambridge.org/artworkguide 
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Image Integrity and Standards 
Any image produced by an instrument (e.g. scanner, microscopy…) with the objective of being used to 
derive quantitative results is considered as original data, and manuscripts that report images without  any 
quantitative findings are not acceptable. Digitalisation of an image converts the image into numerical 
values which can be analysed like any other numerical value. The full information may prove important 
beyond what the author would like to show. Hence images submitted with a  manuscript should be 
minimally processed; some image processing is acceptable (and may be unavoidable), but the final 
image must accurately represent the original data and exclude any misinterpretation of the information 
present in the original image. In case original data are being used just to illustrate a point, this should be 
accompanied by a very clear statement in the manuscript telling the reader this and explaining what is 
being demonstrated. Please refer to the Office of Research Integrity guidelines on image processing in 
scientific publication. 
 
Image Integrity and Standards directions 
 Image acquisition: Equipment and conditions of image acquisition and processing must 
be detailed in the Material and Methods section. This includes the make and model of 
equipment, the acquisition and the image processing software, and the image treatment if any. 
If you export files from an acquisition device, make sure to use a format with no loss of 
information and do not file them into a higher resolution than that of  acquisition. Authors 
have the responsibility to archive original images, with their metadata, in their original format 
without any compression or compressed without loss of information. 
 Preparation of images for a manuscript: For guidance, we refer to the Journal of Cell 
Biology’s instructions to authors 
(http://jcb.rupress.org/site/misc/ifora.xhtml#image_aquisition) which states: 
1) No specific feature within an image may be enhanced, obscured, moved, 
removed, or introduced. 
2) The grouping of images from different parts of the same gel, or from different 
gels, fields, or exposures must be made explicit by the arrangement of the 
figure (i.e., using dividing lines) and in the text of the figure legend. 
3) Adjustments of brightness, contrast, or color balance are acceptable if they are 
applied to every pixel in the image and as long as they do not obscure, 
eliminate, or misrepresent any information present in the original, including 
backgrounds. Non-linear adjustments (e.g., changes to gamma settings) must 
be disclosed in the figure legend. 
For further information, image examples, and more detailed guidance we advise reading 
What’s in a picture? The temptation of image manipulation (reprinted in the Journal of 
Cell Biology (2004) 166, 11-15). 
 If a cropped image is included in the main text of a paper (e.g. a few lanes of a gel), 
display the full original image, including the appropriate controls, the molecular size 
ladder and/or the scale as relevant, as a single figure in a Supplementary Material file  to 
facilitate peer-review and for subsequent on line publication. 
 The statistical analysis applied to the quantitative data associated with images must 
clearly define the statistical unit considered (e.g. the animal, the sample…). 
 Image screening prior to acceptance: All digital images from manuscripts nearing 
acceptance for publication will be screened for any evidence of improper manipulation 
or quality. If the original images cannot be supplied by authors on request, the journal 
reserves the right to reject the submission or to withdraw the published paper. 
 
Supplementary material 
Authors can include supplementary material in any type of text (research article, review article, short 
communication, etc.). Supplementary material will appear only in the electronic version. A link to this 
on-line supplementary material will be included by the Copy Editor at the proof preparation stage. 
Supplementary material will be peer-reviewed along with the rest of the manuscript. The main text of the 
article must stand alone without the supplementary material. Supplementary material should be 
presented according to the instructions for the main text. It will not be copy-edited and authors are 
entirely responsible for the presentation of the supplementary material. 
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Supplementary material directions 
 In the main text, supplementary material are referred to as: 
"Supplementary Table S1", "Supplementary Table S2", etc. for tables; "Supplementary 
Figure S1", "Supplementary Figure S2", etc. for figures; "Supplementary Material S1", 
"Supplementary Material S2", etc. for other material. 
For example: "The list of references used for the meta-analysis is given in Supplementary 
Material S1 and Supplementary Table S1 reports etc." 
 Supplementary material is submitted along with the main manuscript in a separate file 
and identified at uploading as "Supplementary File – for Online Publication Only" 
 The  title  of  the  article  and  the  list  of  authors  are  included  at  the  top  of  the 
supplementary material 
 No line numbering 
 Single spacing 
 Unlike the figures included in the main text, each supplementary figure has its own title 
embedded below the figure 
 
Typographical conventions 
 
Title and headings 
As illustrated and detailed above and in the style sheet (see http://www.animal- 
journal.eu/documents/Animal_style_template.doc), the animal conventions apply to (a) Title of the 
paper, Authors’ names and addresses; (b) Main section headings such as Abstract, Implications, 
Introduction, Material and methods, Results, Discussion, Acknowledgements, References; and (c) 
Subheadings which can be used at two levels only. 
 
Title and heading directions 
 Title – use bold, with an initial capital for the first word only and for words that 
ordinarily take capitals 
 Authors’ names – use lower case with initials in capitals (e.g. J. Doe) 
 Authors' addresses – use italics 
 Headings  are  left  aligned  with  an  initial  capital  for  the  first   word  only,  and   
not numbered 
 Main section headings – use bold with no full stop at the end; text follows on the next 
line (e.g. Abstract) 
 Subheading (level 1) – use italics with no full stop at the end; text follows on the next 
line (e.g. Experimental design) 
 Sub-subheading (level 2) – use italics and end with a full stop; text follows on the same 
line (e.g. Milk fatty acid composition. The fatty acid…) 
 
Abbreviations 
All non-standard abbreviations are defined at first use separately in the abstract and in the main text, they 
should be written in bold capitals at first occurrence. To facilitate the understanding of the manuscript, 
the number of abbreviations should be kept to a minimum (not more than 10 non-standard abbreviations 
is advised). Abbreviations in the short title or in (sub)headings are discouraged. 
 
Abbreviation directions 
 Define abbreviations at first appearance in the abstract, and in the main text 
 Authors should avoid excessive use of non-standard abbreviations (a maximum around 
10 is advised) 
 No author-defined abbreviation in the (short) titles, nor in (sub)headings 
 Abbreviations used in tables/figures have to be defined either as footnotes or in the 
caption 
 Do not start a sentence with an abbreviation 
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  Table 2 Abbreviations that do not require spelling out  
 
Item Definition 
Standard abbreviation  
ACTH Adrenocorticotropic hormone 
ADF Acid detergent fibre 
ADL Acid detergent lignin 
ADP Adenosine diphosphate 
ANOVA Analysis of variance 
ATP Adenosine triphosphate 
BLUP Best linear unbiased prediction 
BW Body weight 
CoA Coenzyme A 
CP 
DM 
Crude protein Dry matter 
DNA Deoxyribonucleic acid 
ELISA Enzyme-linked immunosorbent assay 
FSH Follicle-stimulating hormone 
GLC Gas-liquid chromatography 
GLM General Linear Model 
HPLC High performance (pressure) liquid chromatography 
IGF Insulin-like growth factor 
IR Infrared 
LH Luteinising hormone 
MS Mass spectrometry 
n Number of samples 
NAD Nicotinamide adenine dinucleotide 
NADP Nicotinamide adenine dinucleotide phosphate 
NADPH2 Reduced nicotinamide adenine dinucleotide phosphate 
NDF Neutral detergent fibre 
NIRS Near infrared stectrophotometry 
PAGE Polyacrylamide gel electrophoresis 
PCR 
PMSG 
Polymerase chain reaction Pregnant mare serum 
gonadotropin 
RNA Ribonucleic acid 
SDS Sodium dodecyl sulfate 
UV Ultraviolet 
Statistical standard abbreviation 
CV coefficient of variation 
df degrees of freedom 
EMS expectation of mean square 
F variance ratio 
LSD least significant difference 
MS mean square 
P probability 
use ns P>0.05, in tables 
use * P<0.05, in tables 
use ** P<0.01, in tables 
use *** P<0.001, in tables 
r simple correlation coefficient 
R multiple correlation coefficient 
R2 coefficient of determination 
rSD residual standard deviation 
RMSE root mean square error 
SD standard deviation 
SED standard error of difference 
SEM standard error of mean 
Sy.x standard error of estimate 
2 
chi square 
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The names of the chemicals do not need to be written out in full; chemical symbols are sufficient. Fatty 
acids are abbreviated using the following rules: cis-18:1 for the sum of cis octadecenoic acids. When 
isomers are described, the double bond positions are identified by numbering from the carboxylic acid 
end: c9,t11-18:2; iso-15:0. The terms "omega 3" and "omega 6" are discouraged ed and replaced by "n-
3" and "n-6", e.g. 18:3n-3. Trivial names can be used for the most known fatty acids (myristic, palmitic, 
oleic, linoleic, linolenic) and abbreviations in some cases: CLA for conjugated linoleic acids, EPA for 
eicosapentaenoic acid, DHA for docosahexaenoic acid. Chemical names and trivial names cannot be 
mixed in a same table. 
 
Capitals 
Capitals directions 
 Initial capitals are used for proper nouns, for adjectives formed from proper names, for 
generic names and for names of classes, orders and families 
 Names of diseases are not normally capitalised 
 
Italics 
Use italics for: 
Italics directions 
 Authors’ addresses (see above) 
 Subheadings (see above) 
 Titles for tables (but not captions for figures) 
 Most foreign words, especially Latin words, e.g. ad hoc, ad libitum, et al., in situ, inter 
alia, inter se, in vitro, per se, post mortem, post partum, m. biceps femoris 
but no italics for c.f., corpus luteum, e.g., etc., i.e., NB, via 
 Mathematical unknowns and constants 
 Letters used as symbols for genes or alleles e.g. HbA, Tf D     (but not chromosomes or 
phenotypes of blood groups, transferrins or haemoglobins, e.g. HbAA, TfDD) 
 
Numerals 
Numerals directions 
 In text, use words for numbers zero to nine and figures for higher numbers. In a   series 
of two or more numbers, use figures throughout irrespective of their magnitude 
 Sentences do not, however, begin with figures 
 For values less than unity, 0 is inserted before the decimal point 
 For  large  numbers  in the  text  substitute  10n  for  part  of a number  (e.g.  1.6  106 for 
1 600 000) 
 Do not use comma separator for numbers greater than 999 (e.g. 100 864) 
 The multiplication sign between numbers should be a cross (x) 
 Division of one number by another should be indicated as follows: 136/273. 
 Use figures whenever a number is followed by a standard unit of measurement (e.g. 
100 g, 6 days, 4th week). 
 Use figures for dates, page numbers, class designations, fractions, expressions of  time, 
e.g. 1 January 2007; type 2 
 Dates are given with the month written out in full in the text and with the day in figures 
(i.e. 12 January not 12th January). 
 For time use 24-h clock, e.g. 0905 h, 1320 h 
 
Units of measurement 
The International System of Units (SI) should be used. A list of units is found at 
http://physics.nist.gov/cuu/Units/units.html. Recommendations for conversions and nomenclature 
appeared in Proceedings of the Nutrition Society (1972) 31, 239-247. Some frequently used units   which 
are not in the SI system are accepted: l for litre, ha for hectare, eV for electron-volt, Ci for curie. Day, 
week, month and year are not abbreviated. The international unit for energy (energy value of feeds, etc.) 
is Joule (or kJ or MJ). 
A product of two units should be represented as N·m and a quotient as N/m (e.g. g/kg and not g.kg-1). 
When there are two quotients, present as follows: g/kg per day (not g/kg/day). 
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Concentration or composition 
Composition is expressed as mass per unit mass or mass per unit volume The term content should not be 
used for concentration or proportion. 
 
Submission of the manuscript 
 
Manuscript submission is made electronically through Editorial Manager directly via 
http://www.editorialmanager.com/animal or at www.animal-journal.eu. Any query to the Editorial Office 
should be addressed through this site. Authors can check the status of their manuscript using Editorial 
Manager. Authors should ensure that the email address of the corresponding author is correct. 
 
You must submit separate files for the following: 
 Manuscript  (including  full  text,  tables,  figure  captions,  but  excluding  figures)   in 
DOC/DOCX or RTF format (PDF is not accepted) 
 Each figure (without captions). At submission in Editorial Manager, enter a 
description of each figure (Figure 1, Figure 2a, etc.) in the appropriate box 
 Supplementary online-only materials, if relevant 
 
Authors who submit a manuscript have to also provide in the online submission system: 
- the type of article (research article, short communication, review article, special issue paper, opinion 
paper, etc.). 
- the section of the scope which is the most appropriate for their manuscript. (http://www.animal- 
journal.eu/scope.htm). 
- any comment and information that might be helpful to the editors ("letter to the editor", etc.; in 
"Author's comments"). 
- The names of at least 3 potential reviewers, and give contact details. Reviewers should have no 
conflict of interest with the authors or the submission. Authors should not nominate reviewers who are 
their regular collaborators or who work in the same institution or university, and they should nominate 
an international spread of reviewers. The editorial board will use its discretion when selecting 
reviewers and the suggested reviewers may not be used. 
- The names of maximum 3 opposed reviewers in case of established conflict of interest. 
Any query to the Editorial Office prior to submission of papers (e.g. clarification of instructions to 
authors, to ask if paper is within the scope, etc.) should be addressed through questions@animal- 
journal.eu. 
 
Evaluation of the manuscript 
 
The Editor-in-Chief or the Section Editor may reject manuscripts which do not comply with the scope or 
which do not have the required standard, or which present obvious errors or misinterpretation of results, 
or which do not comply with the recommendations for preparation of articles. The Editor-in- Chief or a 
member of the Editorial Office may also send back to the authors their manuscript for reformatting in the 
style of animal. During the peer-review process, manuscript revisions should be  sent back to the 
Editorial Office within 60 days; otherwise, the manuscript is withdrawn and the revised version will have 
to be submitted as a new manuscript. In order to provide the shortest possible delay from submission to 
acceptance only one revision iteration is expected. Manuscript revisions that do not meet the 
requirements of the handling Editor will be rejected. 
 
Proofs 
 
Authors should not insert new matter into proofs, correct faults in the style, or alter the arrangement of 
their papers at this stage. However, any errors of fact or of logic that have escaped earlier notice must be 
corrected at this stage. Substantial changes will be made at the author’s expense. Authors are advised to 
pay particular attention to checking scientific and proper names, numerical data, formulae, tables and 
illustrations, and list of references. Whilst proof readers are competent in correcting proofs, the ultimate 
responsibility for the correction remains with the author. Indications on how to correct and return the 
proofs are supplied with the proof. Proofs must be sent back to the Publisher within four working days 
of receipt. If this period is exceeded, the pdf proof will be proofed by the Editorial Office without the 
author’s corrections. 
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Copyright agreement 
 
Authors are required formally to transfer copyright to the animal consortium. Two versions of the 
transfer of copyright form (Standard and Open Access) for this purpose may be downloaded at: 
https://www.cambridge.org/core/journals/animal/information/transfer-copyright. The Open Access 
option allows authors in animal the option to make their articles freely available to everyone, 
immediately on publication and after the payment of the Open Access Article Publication Charge 
($2835). 
 
Articles are not further processed until the completed form has been received by the Editorial Office. 
Signing the form does not put any limitation on the personal freedom of authors to use their own 
material contained in their article. 
 
The authors must obtain a written permission to reproduce material that is owned by a third party (for 
example in review papers); they must also include the relevant credit in their paper. The written 
agreements have to be sent to the Editorial Office at submission of their manuscript. 
 
Publication of the manuscript 
 
A free PDF file will be emailed to the corresponding author. To facilitate earlier dissemination, articles 
are published online in FirstView with their doi number at 
https://www.cambridge.org/core/journals/animal ahead of being published as part of an issue. It should 
be stressed that no change in the paper, even quite minor, is possible once the paper is in the FirstView 
list. 
 
 
